

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>New targets for resolution of airway remodeling... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-680/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-680" />
    
            <meta name="description" content="Read the original article in full on F1000Research: New targets for resolution of airway remodeling in obstructive lung diseases" />
    
            <meta name="og:title" content="F1000Research Article: New targets for resolution of airway remodeling in obstructive lung diseases.">
            <meta name="og:description" content="Read the latest article version by Ajay P. Nayak, Deepak A. Deshpande, Raymond B. Penn, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15868">
            <meta name="article-id" content="14581">
            <meta name="dc.title" content="New targets for resolution of airway remodeling in obstructive lung diseases">
            <meta name="dc.description" content="Airway remodeling (AR) is a progressive pathological feature of the obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The pathology manifests itself in the form of significant, progressive, and (to date) seemingly irreversible changes to distinct respiratory structural compartments. Consequently, AR correlates with disease severity and the gradual decline in pulmonary function associated with asthma and COPD. Although current asthma/COPD drugs manage airway contraction and inflammation, none of these effectively prevent or reverse features of AR. In this review, we provide a brief overview of the features and putative mechanisms affecting AR. We further discuss recently proposed strategies with promise for deterring or treating AR.">
            <meta name="dc.subject" content="airway remodeling, asthma, GPCR, smooth muscle">
            <meta name="dc.creator" content="Nayak, Ajay P.">
            <meta name="dc.creator" content="Deshpande, Deepak A.">
            <meta name="dc.creator" content="Penn, Raymond B.">
            <meta name="dc.date" content="2018/05/30">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14581.1">
            <meta name="dc.source" content="F1000Research 2018 7:680">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="airway remodeling">
            <meta name="prism.keyword" content="asthma">
            <meta name="prism.keyword" content="GPCR">
            <meta name="prism.keyword" content="smooth muscle">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/05/30">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="680">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14581.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-680">
            <meta name="citation_title" content="New targets for resolution of airway remodeling in obstructive lung diseases">
            <meta name="citation_abstract" content="Airway remodeling (AR) is a progressive pathological feature of the obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The pathology manifests itself in the form of significant, progressive, and (to date) seemingly irreversible changes to distinct respiratory structural compartments. Consequently, AR correlates with disease severity and the gradual decline in pulmonary function associated with asthma and COPD. Although current asthma/COPD drugs manage airway contraction and inflammation, none of these effectively prevent or reverse features of AR. In this review, we provide a brief overview of the features and putative mechanisms affecting AR. We further discuss recently proposed strategies with promise for deterring or treating AR.">
            <meta name="citation_description" content="Airway remodeling (AR) is a progressive pathological feature of the obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The pathology manifests itself in the form of significant, progressive, and (to date) seemingly irreversible changes to distinct respiratory structural compartments. Consequently, AR correlates with disease severity and the gradual decline in pulmonary function associated with asthma and COPD. Although current asthma/COPD drugs manage airway contraction and inflammation, none of these effectively prevent or reverse features of AR. In this review, we provide a brief overview of the features and putative mechanisms affecting AR. We further discuss recently proposed strategies with promise for deterring or treating AR.">
            <meta name="citation_keywords" content="airway remodeling, asthma, GPCR, smooth muscle">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Ajay P. Nayak">
            <meta name="citation_author_institution" content="Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, USA">
            <meta name="citation_author" content="Deepak A. Deshpande">
            <meta name="citation_author_institution" content="Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, USA">
            <meta name="citation_author" content="Raymond B. Penn">
            <meta name="citation_author_institution" content="Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, USA">
            <meta name="citation_publication_date" content="2018/05/30">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="680">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14581.1">
            <meta name="citation_firstpage" content="680">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-680/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-680.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15868 /> <input type=hidden id=articleId name=articleId value=14581 /> <input type=hidden id=xmlUrl value="/articles/7-680/v1/xml"/> <input type=hidden id=xmlFileName value="-7-680-v1.xml"> <input type=hidden id=article_uuid value=3c767673-f55b-4a88-8419-b0a93f127a51 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="New targets for resolution of airway remodeling in obstructive lung diseases"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14581.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14581.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-680"
  },
  "headline": "New targets for resolution of airway remodeling in obstructive lung diseases",
  "datePublished": "2018-05-30T16:40:56",
  "dateModified": "2018-05-30T16:40:56",
  "author": [
    {
      "@type": "Person",
      "name": "Ajay P. Nayak"
    },    {
      "@type": "Person",
      "name": "Deepak A. Deshpande"
    },    {
      "@type": "Person",
      "name": "Raymond B. Penn"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Airway remodeling (AR) is a progressive pathological feature of the obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The pathology manifests itself in the form of significant, progressive, and (to date) seemingly irreversible changes to distinct respiratory structural compartments. Consequently, AR correlates with disease severity and the gradual decline in pulmonary function associated with asthma and COPD. Although current asthma/COPD drugs manage airway contraction and inflammation, none of these effectively prevent or reverse features of AR. In this review, we provide a brief overview of the features and putative mechanisms affecting AR. We further discuss recently proposed strategies with promise for deterring or treating AR."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-680",
            "name": "New targets for resolution of airway remodeling in obstructive lung..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> New targets for resolution of airway remodeling in obstructive lung... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15868 data-id=14581 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14581.1" data-recommended="" data-doi="10.12688/f1000research.14581.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-680/v1/pdf?article_uuid=3c767673-f55b-4a88-8419-b0a93f127a51" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14581-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14581-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14581-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Nayak AP, Deshpande DA and Penn RB. New targets for resolution of airway remodeling in obstructive lung diseases [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):680 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14581.1" target=_blank>https://doi.org/10.12688/f1000research.14581.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14581-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14581 id=track-article-signin-14581 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14581?target=/articles/7-680">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15868 /> <input name=articleId type=hidden value=14581 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>New targets for resolution of airway remodeling in obstructive lung diseases</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Ajay P. Nayak<a href="https://orcid.org/0000-0003-3437-0096" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3437-0096</div>,&nbsp;</span><span class="">Deepak A. Deshpande,&nbsp;</span><span class=""><a href="mailto:raymond.penn@jefferson.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Raymond B. Penn</span></a></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Ajay P. Nayak<a href="http://orcid.org/0000-0003-3437-0096" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3437-0096</div>,&nbsp;</span><span class="">Deepak A. Deshpande,&nbsp;</span><span class=""><a href="mailto:raymond.penn@jefferson.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Raymond B. Penn</span></a></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 30 May 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14581.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, USA<br/> <p> <div class=margin-bottom> Ajay P. Nayak <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Deepak A. Deshpande <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> <div class=margin-bottom> Raymond B. Penn <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=34739-34308></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=34738-34309></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Airway remodeling (AR) is a progressive pathological feature of the obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The pathology manifests itself in the form of significant, progressive, and (to date) seemingly irreversible changes to distinct respiratory structural compartments. Consequently, AR correlates with disease severity and the gradual decline in pulmonary function associated with asthma and COPD. Although current asthma/COPD drugs manage airway contraction and inflammation, none of these effectively prevent or reverse features of AR. In this review, we provide a brief overview of the features and putative mechanisms affecting AR. We further discuss recently proposed strategies with promise for deterring or treating AR. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> airway remodeling, asthma, GPCR, smooth muscle </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Raymond B. Penn (<a href="mailto:raymond.penn@jefferson.edu">raymond.penn@jefferson.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Raymond B. Penn </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The work in Dr. Penn’s lab is supported by National Institutes of Health (NIH) grants HL58506, AI110007, HL136209, and HL114471. The work in Dr. Deshpande’s lab is supported by NIH grants AG041265 and AI126492. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Nayak AP <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Nayak AP, Deshpande DA and Penn RB. New targets for resolution of airway remodeling in obstructive lung diseases [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):680 (<a href="https://doi.org/10.12688/f1000research.14581.1" target=_blank>https://doi.org/10.12688/f1000research.14581.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 30 May 2018, <b>7</b>(F1000 Faculty Rev):680 (<a href="https://doi.org/10.12688/f1000research.14581.1" target=_blank>https://doi.org/10.12688/f1000research.14581.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 30 May 2018, <b>7</b>(F1000 Faculty Rev):680 (<a href="https://doi.org/10.12688/f1000research.14581.1" target=_blank>https://doi.org/10.12688/f1000research.14581.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d28924e174>Airway remodeling in obstructive lung diseases</h2><p class="" id=d28924e177>Airway remodeling (AR) can be defined as a progressive pathological reorganization of the cellular and molecular constitution of the airway wall. While the onset and rate of progression of structural changes in the airways have been subjects of immense debate, AR has been associated with each of the asthmatic phenotypes<sup><a href="#ref-1">1</a></sup>. Furthermore, the gradual deleterious transformation in lungs can affect airways of all sizes along the bronchial tree. Although the strategies for reversing airway contraction and mitigating airway inflammation have been mainstays of asthma therapy, AR has been clinically intractable. Consequently, a pressing need exists for defining the fundamental pathways contributing to AR pathology and for empowering both basic and clinical research to address this problem. For a comprehensive understanding of the conceptual and practical challenges in AR research, readers are encouraged to review the official research statement of the American Thoracic Society<sup><a href="#ref-2">2</a></sup>. In this current report, we provide an overview of the limitations of currently approved anti-asthma/chronic obstructive pulmonary disease (COPD) drugs in addressing AR and further describe the therapeutic potential of recently proposed approaches for targeting AR.</p><p class="" id=d28924e188>AR was first described in 1922 in patients whose death was attributed to asthma. Necropsy specimens from these patients revealed extensive bronchial mucus plugs and thickening of the airway wall<sup><a href="#ref-3">3</a></sup>. Numerous subsequent clinical investigations have revealed that AR encompasses broad structural changes in the airway that includes thickening of the airway wall, airway smooth muscle (ASM) hyperplasia and hypertrophy, edema, subepithelial fibrosis, increased extracellular matrix (ECM) deposition, immune cell and fibroblast accumulation, angiogenesis, altered matrix composition, goblet cell metaplasia, and mucus hypersecretion<sup><a href="#ref-2">2</a></sup>. A consensus has emerged that multiple cell types (including epithelium, ASM, fibroblasts, and immune cells) contribute to the development of AR in asthma and COPD<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup> (<a href="#T1">Table 1</a>).</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Contribution by distinct cell types to the overall pathology of airway remodeling in obstructive lung diseases.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d28924e220 class=n-a></a><thead><a name=d28924e222 class=n-a></a><tr><a name=d28924e224 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e226 class=n-a></a>Lung cell type</th><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e229 class=n-a></a>Contribution to the pathophysiology of airway remodeling</th></tr></thead><tbody><a name=d28924e234 class=n-a></a><tr><a name=d28924e236 class=n-a></a><td align=left colspan=1 rowspan=8 valign=top><a name=d28924e237 class=n-a></a>Epithelial cells</td><td colspan=1 rowspan=1 valign=top><a name=d28924e240 class=n-a></a>Epithelial shedding</td></tr><tr><a name=d28924e243 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e245 class=n-a></a>Mucus secretion</td></tr><tr><a name=d28924e248 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e250 class=n-a></a>Subepithelial fibrosis</td></tr><tr><a name=d28924e253 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e255 class=n-a></a>Goblet cell hyperplasia</td></tr><tr><a name=d28924e258 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e260 class=n-a></a>Stimulating airway smooth muscle (ASM) proliferation through release<br class=br>of growth factors</td></tr><tr><a name=d28924e266 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e268 class=n-a></a>Recruitment of pro-inflammatory cells</td></tr><tr><a name=d28924e271 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e273 class=n-a></a>Promoting extracellular matrix (ECM) deposition</td></tr><tr><a name=d28924e276 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e278 class=n-a></a>Promoting angiogenesis</td></tr><tr><a name=d28924e281 class=n-a></a><td align=left colspan=1 rowspan=4 valign=top><a name=d28924e282 class=n-a></a>ASM cells</td><td colspan=1 rowspan=1 valign=top><a name=d28924e285 class=n-a></a>Increased ASM mass</td></tr><tr><a name=d28924e288 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e290 class=n-a></a>ASM migration and invasion of the epithelium</td></tr><tr><a name=d28924e293 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e295 class=n-a></a>Adoption of synthetic phenotype (for example, secretion of transforming<br class=br>growth factor-beta, chemokines, and ECM components)</td></tr><tr><a name=d28924e301 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e303 class=n-a></a>Interaction with immune cells through cell adhesion molecules</td></tr><tr><a name=d28924e306 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d28924e307 class=n-a></a>Fibroblasts</td><td colspan=1 rowspan=1 valign=top><a name=d28924e310 class=n-a></a>Differentiation into myofibroblasts and secretion of ECM components</td></tr><tr><a name=d28924e313 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e315 class=n-a></a>Accumulation in subepithelial regions</td></tr></tbody></table></div><p class="" id=d28924e321>The role of the airway epithelium in triggering initial responses and sustaining architectural changes in asthmatic lungs is evident<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. In asthma, repetitive damage to the epithelium from exposure to noxious environmental agents and immune modulators promotes shedding of the epithelium. Consequently, the underlying epithelial-mesenchymal trophic unit may be persistently active and in a reparative state, thus promoting chronic and progressive remodeling of the airway<sup><a href="#ref-8">8</a></sup>. Remodeling manifests in the form of thickening of the epithelial layer, loss of cilia, compromised barrier function, mucus hypersecretion, and ECM remodeling of the subepithelial space<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a>,<a href="#ref-9">9</a>–<a href="#ref-17">17</a></sup>. Moreover, the number of mucus-secreting goblet cells also increases in asthmatics<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. These features collectively contribute to anatomical changes that cause airway narrowing, increased fixed resistance, and mucus plugging of the bronchial lumen.</p><p class="" id=d28924e356>Physiological ASM function is crucial for maintaining adequate airflow. Changes in both ASM responsiveness and morphology occur with asthma, which affects airway resistance and airflow. A critical feature of AR is an increase in ASM mass that contributes significantly to asthma pathology<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. Furthermore, the increased ASM mass and increased airway wall thickness reduce airway lumen area, resulting in increased dynamic and fixed resistance<sup><a href="#ref-21">21</a>–<a href="#ref-26">26</a></sup>. Asthmatic ASM can also acquire a synthetic phenotype, which is characterized by increased secretion of ECM, cytokines, and growth factors. Clinical outcomes associated with bronchial thermoplasty intervention (application of controlled radiofrequency energy to the airway wall) suggest that reducing ASM area is sufficient to improve outcomes in asthmatics<sup><a href="#ref-27">27</a></sup>.</p><p class="" id=d28924e377>Fibroblasts can contribute to AR through increased secretion of ECM<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. Beyond contributing to increased airway wall thickness, ECM components can modulate cellular proliferation and migration. However, the role of fibroblast and ECM components in AR in the context of obstructive lung diseases is not fully understood.</p><p class="" id=d28924e387>The structural changes may contribute toward a gradual decline in lung function and potentially in loss of pulmonary elasticity, leading to hyperinflation and air trapping in lungs. Moreover, remodeling reduces effectiveness of bronchodilatory treatments<sup><a href="#ref-5">5</a>,<a href="#ref-30">30</a>–<a href="#ref-32">32</a></sup>. A correlation between AR and disease severity has been established, but the clinical consequences of AR are yet to be fully understood<sup><a href="#ref-33">33</a>–<a href="#ref-38">38</a></sup>. This lack of knowledge also impacts drug discovery efforts. In the subsequent sections, we review the efficacy of current therapeutics in blunting or reversing AR and discuss novel therapeutic approaches to regulate progression of AR.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28924e410>Overview of current therapeutics and their limitations</h2><p class="" id=d28924e413>Current management of asthma focuses on reversing ASM contraction and mitigating airway inflammation. None of these approaches directly addresses the progressive pathology that causes remodeling in the lung (<a href="#T2">Table 2</a>).</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Current therapeutic targets for asthma management and their effect on airway remodeling.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d28924e430 class=n-a></a><thead><a name=d28924e432 class=n-a></a><tr><a name=d28924e434 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e436 class=n-a></a>Class of<br class=br>therapeutic<br class=br>drugs</th><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e443 class=n-a></a>Target</th><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e446 class=n-a></a>Effect on airway remodeling</th></tr></thead><tbody><a name=d28924e451 class=n-a></a><tr><a name=d28924e453 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e454 class=n-a></a>β-agonists</td><td colspan=1 rowspan=1 valign=top><a name=d28924e457 class=n-a></a>β<sub>2</sub>-AR (beta 2<br class=br>adrenergic receptor)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e465 class=n-a></a>Limited effect on airway remodeling<sup><a href="#ref-5">5</a></sup>. Combination therapy with inhaled<br class=br>corticosteroid limits angiogenesis and fibroblast proliferation<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a>,<a href="#ref-71">71</a></sup>. </td></tr><tr><a name=d28924e484 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e485 class=n-a></a>Inhaled<br class=br>corticosteroids</td><td colspan=1 rowspan=1 valign=top><a name=d28924e490 class=n-a></a>Glucocorticoid<br class=br>receptor</td><td colspan=1 rowspan=1 valign=top><a name=d28924e495 class=n-a></a>Combination therapy with β-agonists limits angiogenesis<sup><a href="#ref-71">71</a></sup>. Mixed anti-<br class=br>proliferative actions on airway smooth muscle cells and human fibroblasts<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>.<br class=br>Reduced mucin secretion and limited extracellular matrix deposition<sup><a href="#ref-61">61</a>–<a href="#ref-64">64</a></sup>.</td></tr><tr><a name=d28924e520 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e521 class=n-a></a>Anti-leukotrienes</td><td colspan=1 rowspan=1 valign=top><a name=d28924e524 class=n-a></a>CysLTR (cysteinyl<br class=br>leukotriene receptor)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e529 class=n-a></a>Moderate effect on airway smooth muscle mass, goblet cell metaplasia, and<br class=br>subepithelial collagen deposition<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a>,<a href="#ref-62">62</a></sup>. Decreased accumulation of fibroblasts<br class=br>in lungs<sup><a href="#ref-47">47</a></sup>.</td></tr></tbody></table></div><p class="" id=d28924e553>As noted earlier, bronchial thermoplasty has been shown to reduce ASM mass in conducting airways of some, but not all, severe asthmatics undergoing the procedure<sup><a href="#ref-27">27</a>,<a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>. This procedure has been shown to significantly reduce collagen deposition in the basement membrane. Although bronchial thermoplasty has been shown to improve quality of life for severe asthmatics in the short term, the cost of the procedure, post-procedure exacerbations, and questions regarding long-term efficacy have limited its application<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d28924e570>Among pharmacological options, β-agonists are the drug of choice for evoking bronchorelaxation in attempting to reverse an acute asthma attack or for providing bronchoprotection when used in combination with an inhaled corticosteroid as a maintenance therapy. However, there is no compelling evidence that β-agonists deter or reverse AR<sup><a href="#ref-5">5</a></sup>. Signaling through cysteinyl leukotriene receptors (CysLTRs) and muscarinic acetylcholine receptors (mAChRs) has been established to promote outcomes that contribute to AR<sup><a href="#ref-42">42</a>–<a href="#ref-44">44</a></sup>. Antagonists of both receptors have shown some utility in preventing AR. Treatment with the CysLTR antagonist montelukast reversed ovalbumin-induced AR by decreasing goblet cell metaplasia, ASM mass, and subepithelial collagen deposition<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. In a cohort of mild asthmatics, montelukast treatment showed reduced accumulation of myofibroblasts in the airway wall, suggesting some potential to mitigate AR<sup><a href="#ref-47">47</a></sup>. Similarly, the long-acting mAChR antagonist, tiotropium, has demonstrated a robust ability in preventing AR in rodent (guinea pig and mouse) models of ovalbumin-induced asthma and lipopolysaccharide-induced COPD<sup><a href="#ref-48">48</a>–<a href="#ref-52">52</a></sup>. Overall, although some evidence suggests that mAChR and CysLTR antagonists may have utility in deterring AR, additional studies in humans are necessary to establish the true effectiveness of these drugs in preventing or reversing AR<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d28924e608>Persistent asthma is commonly treated with inhaled corticosteroids either as a monotherapy or in combination with a β-agonist or mAChR antagonist. In epithelial cells, corticosteroids limit the inflammatory response and induce apoptosis<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. <i>In vitro</i>, multiple corticosteroids have been shown to significantly inhibit fibroblast proliferation either alone or in combination with β-agonists<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. Similar anti-proliferative effects have also been reported with corticosteroids in ASM cells stimulated with distinct mitogenic agents<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. However, others have shown that corticosteroids have no effect on ASM proliferation<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. While corticosteroids inhibit growth factor–stimulated proliferation of ASM cells sourced from healthy controls, this effect was lacking on ASM cells from asthmatics<sup><a href="#ref-59">59</a></sup>. In animal models, dexamethasone has been shown to reduce goblet cell metaplasia; however, this treatment showed no effect on ASM mass and subepithelial fibrosis<sup><a href="#ref-45">45</a></sup>. In humans, in conjunction with limiting inflammation and airway hyperresponsiveness, corticosteroid treatment can also reduce mucin secretion and limit ECM deposition and AR<sup><a href="#ref-61">61</a>–<a href="#ref-64">64</a></sup>. However, others have shown that corticosteroids have a mixed effect on the resolution of subepithelial fibrosis<sup><a href="#ref-65">65</a>–<a href="#ref-70">70</a></sup>. Collectively, studies to date indicate a need for developing better therapeutic drugs for targeting AR pathology in obstructive lung diseases.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28924e668>New targets and approaches for airway remodeling</h2><p class="" id=d28924e671>In recent years, basic science research has begun to provide insight into the mechanisms, mediated by multiple cell types, that promote AR and these studies help to inform potential strategies for managing AR. Certain approaches that show promise in mitigating features of AR have recently been proposed (<a href="#T3">Table 3</a>).</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Anti-remodeling effects of novel therapeutic approaches (<i>in vitro</i>, animal, and human studies).</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d28924e691 class=n-a></a><thead><a name=d28924e693 class=n-a></a><tr><a name=d28924e695 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e697 class=n-a></a>Class of therapeutic drugs</th><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e700 class=n-a></a>Target</th><th align=left colspan=1 rowspan=1 valign=top><a name=d28924e703 class=n-a></a>Potential effect on airway remodeling (AR)</th></tr></thead><tbody><a name=d28924e708 class=n-a></a><tr><a name=d28924e710 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d28924e711 class=n-a></a>G protein–coupled receptor<br class=br>modulators</td><td colspan=1 rowspan=1 valign=top><a name=d28924e716 class=n-a></a>E-prostanoid receptors</td><td colspan=1 rowspan=1 valign=top><a name=d28924e719 class=n-a></a>Suppression of airway smooth muscle (ASM) proliferation<sup><a href="#ref-72">72</a>–<a href="#ref-74">74</a></sup>.</td></tr><tr><a name=d28924e729 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e731 class=n-a></a>Bitter taste receptors (TAS2Rs)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e734 class=n-a></a>Regulation of ASM proliferation<sup><a href="#ref-81">81</a>,<a href="#ref-82">82</a></sup>. Reversal of allergen-<br class=br>induced AR features, including ASM mass<sup><a href="#ref-83">83</a></sup>. Alteration of<br class=br>mitochondrial function and induction of autophagy<sup><a href="#ref-84">84</a></sup>.</td></tr><tr><a name=d28924e756 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d28924e757 class=n-a></a>Biologics</td><td colspan=1 rowspan=1 valign=top><a name=d28924e760 class=n-a></a>Interleukin-5 (IL-5) cytokine</td><td colspan=1 rowspan=1 valign=top><a name=d28924e763 class=n-a></a>Reduced subepithelial fibrosis and extracellular matrix (ECM)<br class=br>deposition<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>.</td></tr><tr><a name=d28924e775 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e777 class=n-a></a>Immunoglobulin E</td><td colspan=1 rowspan=1 valign=top><a name=d28924e780 class=n-a></a>Reduced thickening of reticular lamina<sup><a href="#ref-87">87</a></sup>.</td></tr><tr><a name=d28924e787 class=n-a></a><td align=left colspan=1 rowspan=4 valign=top><a name=d28924e788 class=n-a></a>Mitogen-activated protein<br class=br>kinase (MAPK) inhibitors</td><td colspan=1 rowspan=1 valign=top><a name=d28924e793 class=n-a></a>MEK1 (MAPK kinase)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e796 class=n-a></a>Regulation of mucus secretion<sup><a href="#ref-88">88</a>,<a href="#ref-89">89</a></sup>. </td></tr><tr><a name=d28924e807 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e809 class=n-a></a>p38</td><td colspan=1 rowspan=1 valign=top><a name=d28924e812 class=n-a></a>Reduced ASM mass and goblet cell metaplasia<sup><a href="#ref-90">90</a></sup>.</td></tr><tr><a name=d28924e819 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e821 class=n-a></a>c-Jun N-terminal kinases (JNKs)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e824 class=n-a></a>Reduced mucus secretion and expansion of goblet cells<sup><a href="#ref-91">91</a>,<a href="#ref-92">92</a></sup>.<br class=br>Reduced proliferation of ASM and epithelial cells<sup><a href="#ref-93">93</a></sup>.</td></tr><tr><a name=d28924e840 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e842 class=n-a></a>Transforming growth factor-<br class=br>beta-activated kinase 1 (TAK1)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e847 class=n-a></a>Reduced synthesis of IL-8 in ASM cells and reduced<br class=br>proliferation<sup><a href="#ref-94">94</a>,<a href="#ref-95">95</a></sup>. </td></tr><tr><a name=d28924e859 class=n-a></a><td align=left colspan=1 rowspan=5 valign=top><a name=d28924e860 class=n-a></a>Receptor tyrosine kinase<br class=br>inhibitors</td><td colspan=1 rowspan=3 valign=top><a name=d28924e865 class=n-a></a>Epidermal growth factor<br class=br>receptor</td><td colspan=1 rowspan=1 valign=top><a name=d28924e870 class=n-a></a>Reduced proliferation of ASM and epithelial cells<sup><a href="#ref-96">96</a>–<a href="#ref-98">98</a></sup>.</td></tr><tr><a name=d28924e880 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e882 class=n-a></a>Regulation of mucus secretion<sup><a href="#ref-99">99</a>–<a href="#ref-102">102</a></sup>.</td></tr><tr><a name=d28924e892 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e893 class=n-a></a>Reduced ASM thickening and goblet cell metaplasia<sup><a href="#ref-103">103</a></sup>.</td></tr><tr><a name=d28924e901 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e903 class=n-a></a>Platelet-derived growth factor<br class=br>receptor</td><td colspan=1 rowspan=1 valign=top><a name=d28924e908 class=n-a></a>Reduced ASM proliferation<sup><a href="#ref-104">104</a></sup>. </td></tr><tr><a name=d28924e915 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e917 class=n-a></a>Stem cell growth factor receptor<br class=br>(c-kit)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e922 class=n-a></a>Attenuated collagen accumulation in lungs<sup><a href="#ref-105">105</a></sup>.</td></tr><tr><a name=d28924e929 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d28924e930 class=n-a></a>Non-receptor tyrosine kinase<br class=br>inhibitors</td><td colspan=1 rowspan=1 valign=top><a name=d28924e935 class=n-a></a>Spleen tyrosine kinase (Syk)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e938 class=n-a></a>Reduced bronchial edema<sup><a href="#ref-106">106</a></sup>.</td></tr><tr><a name=d28924e945 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e947 class=n-a></a>Janus kinase (JAK)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e950 class=n-a></a>Reduced expression of Gob-5<sup><a href="#ref-107">107</a></sup>. </td></tr><tr><a name=d28924e957 class=n-a></a><td align=left colspan=1 rowspan=2 valign=top><a name=d28924e958 class=n-a></a>Other kinase inhibitors</td><td colspan=1 rowspan=1 valign=top><a name=d28924e961 class=n-a></a>TGF-β receptor type I (T-βRI)<br class=br>kinase</td><td colspan=1 rowspan=1 valign=top><a name=d28924e966 class=n-a></a>Diminished collagen deposition and reduced proliferation of<br class=br>ASM and epithelial cells in lungs<sup><a href="#ref-108">108</a></sup>. </td></tr><tr><a name=d28924e975 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e977 class=n-a></a>Rho-associated protein kinase<br class=br>(ROCK)</td><td colspan=1 rowspan=1 valign=top><a name=d28924e982 class=n-a></a>Curtailed ECM remodeling process<sup><a href="#ref-109">109</a></sup>.</td></tr><tr><a name=d28924e990 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d28924e991 class=n-a></a>Phosphodiesterase (PDE)<br class=br>inhibitors</td><td colspan=1 rowspan=1 valign=top><a name=d28924e996 class=n-a></a>PDEs</td><td colspan=1 rowspan=1 valign=top><a name=d28924e999 class=n-a></a>Marked reduction in subepithelial fibrosis and epithelial layer<br class=br>thickening<sup><a href="#ref-110">110</a></sup>. Reduced proliferation of ASM<sup><a href="#ref-111">111</a></sup>.</td></tr></tbody></table></div><div class=section><a name=d28924e1015 class=n-a></a><h3 class=section-title>(Other) G protein–coupled receptor ligands</h3><p class="" id=d28924e1020>G protein–coupled receptors (GPCRs) play a substantial role in numerous normal physiological functions. Unsurprisingly, they can contribute towards the pathophysiology of various diseases. As noted earlier, GPCR agonists (of the β2-adrenergic receptor) and antagonists (of the mAChRs and CysLTR) are principal drugs in the management of asthma and COPD. In this section, we provide a brief overview of novel targets, the drugs that modulate them, and the potential of such drugs to address AR pathology.</p><p class="" id=d28924e1023><b><i>E-prostanoid receptor agonists.</i></b> The role of prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) and E-prostanoid (EP) receptor subtypes in mitigating AR has been a subject of recent research. Early studies demonstrated that autocrine PGE<sub>2</sub>, generated as a consequence of cytokine-induced cyclooxygenase-2 induction, significantly suppresses mitogen-induced ASM proliferation <i>in vitro</i><sup><a href="#ref-72">72</a></sup>. Furthermore, studies of cultured human ASM in our laboratory have demonstrated that exogenous PGE<sub>2</sub> shows relatively superior anti-mitogenic activity in comparison to multiple β-agonists with anti-mitogenic effects corresponding to drug efficacy in activating the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) axis<sup><a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>. Application of PGE<sub>2</sub> in humans has been hindered by the ability of PGE<sub>2</sub> to signal through multiple receptor subtypes (EP1–4)<sup><a href="#ref-75">75</a>–<a href="#ref-79">79</a></sup>, which contributes to undesirable side effects. It is now known that the cough response is mediated by PGE<sub>2</sub> activation of the EP3 receptor on vagal sensory nerves<sup><a href="#ref-80">80</a></sup>. Additionally, studies in our lab have shown that EP3 receptor signaling has a pro-mitogenic role in ASM<sup><a href="#ref-74">74</a></sup>. To overcome the heterogeneity of PGE<sub>2</sub> signaling, the development of EP receptor subtype–specific modulators that specifically promote Gs-cAMP-PKA axis activity (via EP2 and EP4 subtypes) has been purposed<sup><a href="#ref-84">84</a>,<a href="#ref-112">112</a>–<a href="#ref-114">114</a></sup>. Currently, our lab is evaluating various strategies of targeting specific EP receptor subtypes in pre-clinical models of allergen-induced asthma<sup><a href="#ref-84">84</a></sup>.</p><p class="" id=d28924e1097><b><i>Bitter taste receptors.</i></b> Recently, our laboratory showed that bitter taste receptor (TAS2R) agonists can limit proliferation of ASM cells <i>in vitro</i><sup><a href="#ref-81">81</a>,<a href="#ref-82">82</a></sup>. Mechanistically, TAS2R agonists restrict ASM proliferation by inhibiting (1) the growth factor–activated protein kinase B (Akt) phosphorylation; (2) transcription factors AP-1, STAT3, E2 factor, and NFAT; and (3) genes associated with cell cycle progression.</p><p class="" id=d28924e1112>The anti-mitogenic effects of TAS2R agonists further translate to pre-clinical asthma models as well. In a chronic allergen (ovalbumin or house dust mite) challenge model, treatment with bitter taste compounds (chloroquine and quinine) significantly reversed remodeling features<sup><a href="#ref-83">83</a></sup>. Specifically, treatment with bitter compounds inhibited the expression of calponin, smooth muscle alpha-actin, and smooth muscle myosin heavy chain in lungs. Furthermore, levels of matrix metallopeptidase-8 (MMP-8) (neutrophil collagenase), pro-MMP-9 (gelatinase), and MMP-12 (macrophage metalloelastase) were significantly reduced in lungs following treatment with TAS2R agonists. Finally, allergen-induced expression of pro-fibrotic cytokine transforming growth factor-beta (TGF-β) as well as phospho-mothers against decapentaplegic homolog 2 (pSmad2) and fibronectin in the lung tissue was also curtailed by TAS2R agonists. Collectively, these studies indicate that TAS2R agonists, unlike current GPCR ligands used to treat asthma, address multiple features of asthma pathology, including AR. Advancements in the development of selective ligands for TAS2R subtypes will allow for a refined therapeutic approach in the near future.</p><p class="" id=d28924e1120>Bitter tastants have also been shown to modulate function of ciliated epithelial cells<sup><a href="#ref-115">115</a></sup>. Specifically, the motile cilia on human airway epithelia express TAS2Rs (T2R4, T2R43, T2R38, and T2R46). The organization of TAS2Rs on cilia with the distribution of the signaling machinery along the ciliary shaft and within the attached epithelial cell presents an interesting mechanical apparatus for signal transduction. Stimulation of TAS2Rs with bitter tastants induces transient Ca<sup>2+</sup> flux within the epithelial cells and increases ciliary beat frequency. Functionally, promoting increased ciliary movement could be beneficial in the removal of excess mucus from the airways.</p><p class="" id=d28924e1130>In recent years, the role of mitochondrial dysfunction in disease states, including obstructive lung diseases, has become increasingly clear<sup><a href="#ref-116">116</a>,<a href="#ref-117">117</a></sup>. Specifically, a role for autophagy/mitophagy in regulating mitochondrial function in pathophysiology of obstructive lung diseases is emerging. As noted earlier, our studies show that activation of TAS2Rs can promote anti-mitogenic activities. Further explorations into the mechanisms that underlie the anti-mitogenic effects of TAS2R agonists have uncovered an interesting role for bitter tastants in altering mitochondrial function and inducing autophagy<sup><a href="#ref-82">82</a></sup>. TAS2R agonists can induce changes in mitochondrial membrane potential, increase reactive oxygen species generation, and promote mitochondrial fragmentation. These observations provide insight into the broader therapeutic potential of targeting mitochondrial function and promoting autophagy to restrict cellular proliferation.</p></div><div class=section><a name=d28924e1145 class=n-a></a><h3 class=section-title>Biologics</h3><p class="" id=d28924e1150>Asthma pathology is orchestrated by multiple immunologic mediators (cellular and secreted)<sup><a href="#ref-118">118</a></sup>. Consequently, in recent years, therapies that target specific cytokines or immune cells to disrupt immune networks responsible for asthma pathology have gained significant interest. Targeting key cytokines with specific antibodies—biologics, including antibodies targeting interleukin-4 (IL-4), IL-5, and IL-13—can significantly limit recruitment of inflammatory cells to the lungs or blunt their pleiotropic effects. For instance, anti–IL-5 treatment can significantly reduce the number of circulating eosinophils in asthmatics and improve lung function<sup><a href="#ref-119">119</a>–<a href="#ref-121">121</a></sup>. Anti–IL-5 treatment has been shown to prevent the development of subepithelial fibrosis in a murine model of asthma and reduce incorporation of proteoglycans in the human airway wall<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>. However, antibodies targeting other cytokines or their receptors have not been studied in the context of AR<sup><a href="#ref-122">122</a></sup>. Collectively, the data on the effects of biologics on AR are lacking and this is possibly due to the relatively recent development of these drugs. Future longitudinal studies that evaluate biologics in the context of remediation of AR features are needed to address the utility of these drugs as anti-AR agents.</p><p class="" id=d28924e1175>Allergen-specific immunoglobulin E (IgE) isotype antibodies can cross-link on mast cells and basophils, causing degranulation and release of histamine, cytokines, and growth factors<sup><a href="#ref-123">123</a></sup>. Biologics that block the interactions of IgE antibodies to the high-affinity FcεRI receptors on mast cells and antigen presenting cells can curtail the sensitization profile in asthmatics and reduce exacerbations. In severe asthmatics evaluated for 36 months, blocking IgE activity was sufficient to reduce the thickening of the reticular lamina, thereby having an impact on AR<sup><a href="#ref-87">87</a></sup>.</p><p class="" id=d28924e1186>Although biologics have become an increasingly important tool in the management of severe asthma, their application in the clinic has some drawbacks<sup><a href="#ref-124">124</a>–<a href="#ref-126">126</a></sup>. Application of cytokine-specific antibody therapy is limited by the heterogeneity of asthma phenotypes<sup><a href="#ref-127">127</a></sup>. Non-atopic asthmatics are also not suitable for certain therapy (for example, anti-IgE). Biologics can also cause side effects such as hypersensitivity reactions, although the underlying mechanisms are unclear. Finally, there is also significant cost associated with the use of biologics.</p></div><div class=section><a name=d28924e1202 class=n-a></a><h3 class=section-title>Kinase inhibitors</h3><p class="" id=d28924e1207>Kinase enzymes modulate multiple cellular functions by regulating various signaling networks, including those regulating cellular proliferation and growth. Consequently, inhibitors that target various kinases have received increasing attention. Modulators of kinase functions account for one third of drugs in the development pipeline, and the majority of these represent cancer therapeutics<sup><a href="#ref-128">128</a></sup>. In this section, we provide a brief overview of drugs that target distinct kinases. For a more comprehensive discussion of targeting kinases in the context of obstructive lung diseases, the reader is referred to<sup><a href="#ref-129">129</a></sup>.</p><p class="" id=d28924e1218> <b> <i>Mitogen-activated protein kinase inhibitors.</i> </b> Mitogen-activated protein kinases (MAPKs) have been studied extensively for their contribution to inflammatory gene expression and activation of multiple networks that contribute to the pathophysiology of obstructive lung diseases<sup><a href="#ref-130">130</a></sup>. Extracellular signal-regulated kinases (ERK1/2) are particularly interesting given that they are activated in multiple cell types that contribute to asthma and COPD pathology<sup><a href="#ref-88">88</a>,<a href="#ref-131">131</a>,<a href="#ref-132">132</a></sup>. Inhibition of ERK kinase (MAPK1, or MEK1) which is upstream of ERK1/2 can significantly reduce mucin 5AC, oligomeric mucus/gel-forming (<i>MUC5AC</i>) expression in cultured human bronchial epithelial cells subjected to chronic mechanical stress at the air-liquid interface<sup><a href="#ref-88">88</a>,<a href="#ref-89">89</a></sup>. Other MAPKs, such as p38, c-Jun N-terminal kinase (JNK), and transforming growth factor beta-activated kinase 1 (TAK1), are activated in asthma and COPD<sup><a href="#ref-129">129</a></sup>, and inhibitors of these targets can mitigate various features of AR in both cell and animal asthma models<sup><a href="#ref-90">90</a>–<a href="#ref-95">95</a></sup>. However, to date, no studies in humans have evaluated these inhibitors. Another limitation of kinase inhibitors is that these compounds are predominantly inhibitors of ATP-competitive and catalytic sites and block all enzymatic activity, including MAPK functions important for normal physiological activity in cells. Given the ubiquitous functions of the MAPK signaling pathway, development of substrate-selective MAPK inhibitors with the goal of targeting specific kinase functions associated with disease, while preserving kinase functions in normal cells, appears necessary to overcome limitations of off-target effects.</p><p class="" id=d28924e1263><b><i>Receptor tyrosine kinase inhibitors.</i></b> Receptor tyrosine kinases (RTKs) occupy a central role in critical signaling networks that promote asthma pathology, including remodeling<sup><a href="#ref-133">133</a></sup>. With inflammation, distinct RTKs and their ligands (for example, epidermal growth factor) are upregulated in human asthmatic airways and show a strong correlation with disease severity<sup><a href="#ref-134">134</a>–<a href="#ref-143">143</a></sup>. RTKs can stimulate pathophysiological functions in ASM and epithelial cells. Thus, significant interest in advancing tyrosine kinase inhibitors for targeting RTKs has developed.</p><p class="" id=d28924e1280>Activation of epidermal growth factor receptor (EGFR) is essential for mucus secretion and goblet cell metaplasia<sup><a href="#ref-144">144</a></sup>. It is also responsible for sustaining oxidative damage in the epithelial compartment through recruitment of neutrophils in a TGF-β–dependent manner<sup><a href="#ref-145">145</a>–<a href="#ref-148">148</a></sup>. EGFR inhibitors tyrphostin AG1478 and BIBX1522 have been evaluated <i>in vitro</i> and in animal models of lung inflammation<sup><a href="#ref-99">99</a>–<a href="#ref-101">101</a></sup>. Collectively, these studies report significant reductions in expression of mucus-associated <i>MUC5AC</i> gene and mucin secretion. More importantly, there is a concomitant reduction in collagen deposition and ASM proliferation<sup><a href="#ref-96">96</a>–<a href="#ref-98">98</a></sup>. Although these observations are encouraging, some inhibitors of EGFR have failed to produce similar outcomes in clinical studies<sup><a href="#ref-149">149</a></sup>. Activation of platelet-derived growth factor receptor (PDGFR) has been shown to stimulate ASM proliferation <i>in vitro</i> and <i>in vivo</i><sup><a href="#ref-138">138</a>,<a href="#ref-150">150</a>,<a href="#ref-151">151</a></sup>. Multiple drugs targeting PDGFR can mitigate ASM proliferation <i>in vitro</i>, although animal and human studies that address AR are lacking<sup><a href="#ref-104">104</a></sup>. In severe corticosteroid-dependent asthmatics, treatment with the tyrosine kinase inhibitor mastinib has shown improved outcomes; however, some adverse effects, including skin rash and edema, have also been reported<sup><a href="#ref-152">152</a></sup>. During airway inflammation, multiple cell types (immune and resident) can be stimulated to secrete angiogenic factors, including vascular endothelial growth factor (VEGF)<sup><a href="#ref-153">153</a>–<a href="#ref-159">159</a></sup>. These angiogenic factors can further stimulate increase in formation of new blood vessels from endothelial cells in the subepithelial mucosa<sup><a href="#ref-160">160</a>–<a href="#ref-162">162</a></sup>. Although the contribution of neovascularization in AR is unclear, it has been suggested that newly formed vasculature is permeable, thus contributing to edema and limiting airflow<sup><a href="#ref-71">71</a>,<a href="#ref-161">161</a>,<a href="#ref-163">163</a>,<a href="#ref-164">164</a></sup>. An antagonist of VEGFR-1 and VEGFR-2 (SU5416) has been shown to limit inflammatory responses in animals<sup><a href="#ref-165">165</a></sup>, although its impact on AR is unknown and studies in humans are lacking.</p><p class="" id=d28924e1378>Because multiple RTKs contribute to pathology of AR, a novel strategy that targets multiple RTKs has gained momentum. In a pre-clinical murine model of ovalbumin-induced asthma, treatment with nintedanib—a small-molecule inhibitor that targets multiple RTKs (VEGFR, fibroblast growth factor receptor, and PDGFR)—significantly improved indices of remodeling and airway inflammation<sup><a href="#ref-166">166</a></sup>. This approach could be useful in targeting multiple redundant RTK networks that contribute to AR. Finally, inhibitors of non-RTKs, such as stem cell growth factor receptor (c-kit), spleen tyrosine kinase (SYK), the proto-oncogene tyrosine-protein kinase Src, and Janus kinase (JAK), have also been investigated in rodent models of asthma but have not yet progressed to studies in humans<sup><a href="#ref-105">105</a>,<a href="#ref-106">106</a>,<a href="#ref-167">167</a>–<a href="#ref-171">171</a></sup>.</p><p class="" id=d28924e1398><b><i>Other kinase inhibitors.</i></b> Diverse stimuli (cytokines, viruses, growth factors, free radicals, and so on) can activate the transcription factor nuclear factor-kappa B (NF-κB) in multiple airway cell types. This transcription factor plays a key role in orchestrating immune responses and thus multiple intra- and inter-cell inflammatory signals<sup><a href="#ref-129">129</a></sup>. Although inhibitors that target activation of NF-κB have been shown to suppress certain synthetic functions of ASM<sup><a href="#ref-172">172</a></sup> and modulate pro-inflammatory outcomes in epithelial cells<sup><a href="#ref-173">173</a></sup>, specific NF-κB inhibitors have not translated into clinical trials for asthma and this is due to their multiple side effects<sup><a href="#ref-129">129</a></sup>. Inhibitors of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI-3K) that regulate cellular lipids and coordinate inflammatory pathways have undergone extensive investigation in asthma and COPD<sup><a href="#ref-174">174</a>,<a href="#ref-175">175</a></sup>. However, data assessing AR indices are lacking. TGF-β plays an important role in cellular proliferation and differentiation and its expression increases in asthmatic airways, especially in the submucosal compartment<sup><a href="#ref-176">176</a>–<a href="#ref-178">178</a></sup>. TGF-β has also been implicated in AR and can promote proliferation in ASM<sup><a href="#ref-179">179</a>,<a href="#ref-180">180</a></sup>. TGF-β activates TGF-β receptor type I (T-βRI) kinase, which in turn activates Smad-dependent signaling that regulates expression of various genes. Small-molecule inhibitors of (T-βRI) kinase have yielded mixed results in studies assessing their effects on mechanisms mediating AR. T-βRI kinase inhibitors have been shown to diminish collagen deposition in lungs of rats challenged repeatedly with an allergen<sup><a href="#ref-108">108</a></sup>. <i>In vitro</i>, T-βRI inhibitors have demonstrated the ability to limit ASM proliferation, although their use in animal studies failed to inhibit TGF-β–induced increases in ASM mass<sup><a href="#ref-108">108</a>,<a href="#ref-181">181</a></sup>. Clinical application of these inhibitors has been limited due to adverse effects, including cardiotoxicity in clinical trials for cancer therapy<sup><a href="#ref-182">182</a></sup>. Protein kinase C (PKC) is another target of interest given its ability to promote contractile signaling in ASM following activation of Gq-coupled GPCRs. PKC is also relevant to AR because of its role in ASM proliferation<sup><a href="#ref-183">183</a></sup> and mucus secretion in epithelium<sup><a href="#ref-148">148</a></sup>. Owing to severe toxicity, non-selective inhibitors of PKC have not progressed to clinical trials<sup><a href="#ref-129">129</a>,<a href="#ref-184">184</a></sup>. Selective inhibitors of PKC isoforms have been developed for clinical studies for treatment of cancer, metabolic diseases, and psychiatric disorders, although adverse effects have been problematic and no clinical trials have been conducted for treatment of obstructive lung diseases in humans<sup><a href="#ref-129">129</a>,<a href="#ref-184">184</a></sup>. Finally, Rho-associated protein kinase (ROCK) inhibitors have been shown to mitigate multiple features of asthma, including AR in guinea pig and murine models<sup><a href="#ref-109">109</a>,<a href="#ref-185">185</a></sup>. Although ROCK inhibitors have been approved for certain indications, clinical trials in asthma or COPD are lacking<sup><a href="#ref-129">129</a></sup> as issues regarding selectivity and toxicity have limited progression of these inhibitors to clinical application in airway diseases<sup><a href="#ref-129">129</a></sup>.</p><p class="" id=d28924e1499>In summary, <i>in vitro</i> studies of pharmacological inhibition of multiple kinases that contribute to dysfunction in ASM and epithelium have yielded promising results<sup><a href="#ref-181">181</a>,<a href="#ref-186">186</a></sup>. However, certain limitations have stalled progression of many drugs for clinical use. Specificity, efficacy, solubility issues, and poor pharmacokinetic profiles plague drug development<sup><a href="#ref-187">187</a></sup>. With chronic inhibitor treatment, compensatory signaling by other kinases may limit drug efficacy; this appears to be the case with p38 isoform inhibitors<sup><a href="#ref-129">129</a>,<a href="#ref-188">188</a></sup>. Inhibition of any widely expressed kinase runs the risk of adverse effects. For example, given that NF-κB is crucial for mounting an immune response to microbial pathogens, blocking its activation could render patients susceptible to life-threatening infections<sup><a href="#ref-129">129</a></sup>. Current challenges in developing effective and safe kinase inhibitors hinge on improving the poor solubility, selectivity, and targeting of the current versions of these drugs<sup><a href="#ref-129">129</a></sup>.</p></div><div class=section><a name=d28924e1533 class=n-a></a><h3 class=section-title>Other small-molecule inhibitors</h3><p class="" id=d28924e1538>Phosphodiesterase (PDE) inhibitors have a beneficial effect of promoting ASM relaxation by increasing intracellular cAMP resulting in PKA-mediated ASM relaxation. In murine models of asthma, PDE inhibitors have also been shown to curtail inflammation and reduce AR<sup><a href="#ref-110">110</a></sup>. Inhibition of PDE3 (but not PDE4) has anti-proliferative action on mitogen-activated human ASM cells <i>in vitro</i>, but as with most potential anti-AR drugs, useful <i>in vivo</i> data are lacking<sup><a href="#ref-111">111</a></sup>. More recently, an inhibitor of PDE8 (PF-04957325) has been shown to regulate proliferation of ASM cells by enhancing cAMP accumulation generated specifically from the β2-AR/AC6 pathway<sup><a href="#ref-189">189</a></sup>.</p><p class="" id=d28924e1559>The rapamycin derivative SAR-943 has been shown to limit the mitogen-induced proliferation of human ASM cells (but not human epithelial cells) <i>in vitro</i> and mitigate inflammation and AR <i>in vivo</i> in ovalbumin-challenged mice<sup><a href="#ref-190">190</a></sup>, yet no clinical studies for asthma or COPD have been reported.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28924e1576>Conclusions</h2><p class="" id=d28924e1579>The correlation between AR and obstructive lung disease severity suggests a strong pathogenic role of AR in these diseases. Thus, remediation of AR appears critical for improving the severity and progression of these diseases. A growing arsenal of small-molecule inhibitors and biologics in conjunction with non-pharmacological interventions such as bronchial thermoplasty has shown promise in addressing this unmet clinical need. As our understanding of mechanisms underlying AR improves, so will the drug development approaches as well as the phenotyping capabilities that accurately assess AR in humans. These advances will undoubtedly fulfill our need for more refined, efficacious, and safer drugs that enable us to finally control the entire spectrum of asthma pathology.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28924e1585>Abbreviations</h2><p class="" id=d28924e1588>AR, airway remodeling; β<sub>2</sub>-AR, beta 2 adrenergic receptor; ASM, airway smooth muscle; cAMP, cyclic adenosine monophosphate; c-kit, Stem cell growth factor receptor; COPD, chronic obstructive pulmonary disease; CysLTR, cysteinyl leukotriene receptor; ECM, extracellular matrix; EGFR, epidermal growth factor receptor; EP, E prostanoid; ERK1/2, extracellular signal-regulated kinases 1/2; GPCR, G protein–coupled receptor; FGFR, fibroblast growth factor receptor; ICS, inhaled corticosteroids; IgE, immunoglobulin E; IL, interleukin; JAK, Janus kinase; JNK, c-Jun N-terminal kinase; mAChR, muscarinic acetylcholine receptor; MAPK, mitogen-activated protein kinase; MEK1, mitogen-activated protein kinase kinase 1; MMP, matrix metalloproteinase; MUC5AC: mucin 5AC, oligomeric mucus/gel-forming; NF-κB, nuclear factor-kappa B; PDE, phosphodiesterase; PDGFR, platelet-derived growth factor receptor; PGE<sub>2</sub>, prostaglandin E<sub>2</sub>; PI-3K, phosphatidylinositol-4,5 bisphosphate 3-kinase; PKA, protein kinase A; PKC, protein kinase C; ROCK, Rho-associated proteinase kinase; RTK, receptor tyrosine kinase; Smad2: Mothers against decapentaplegic homolog 2; Syk, spleen tyrosine kinase; TAK1, Transforming growth factor-β-activated kinase 1; TAS2R, bitter taste receptor; TGF-β, transforming growth factor-beta; T-βRI, transforming growth factor-beta receptor type I kinase; VEGFR; vascular endothelial growth factor receptor</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d28924e1 class=n-a></a><h2 class=main-title id=d29430>Competing interests</h2><p class=metadata-entry><a name=d28924e105 class=n-a></a><p id=d28924e106> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d28924e1 class=n-a></a><h2 class=main-title id=d29432>Grant information</h2><p>The work in Dr. Penn’s lab is supported by National Institutes of Health (NIH) grants HL58506, AI110007, HL136209, and HL114471. The work in Dr. Deshpande’s lab is supported by NIH grants AG041265 and AI126492.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d28924e1604 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d30049>References</h2><div class="section ref-list"><a name=d28924e1604 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d28924e1611 class=n-a></a>James AL, Maxwell PS, Pearce-Pinto G, <i> et al.</i>: The relationship of reticular basement membrane thickness to airway wall remodeling in asthma. <i>Am J Respir Crit Care Med.</i> 2002; <b>166</b>(12 Pt 1): 1590–5. <a target=xrefwindow id=d28924e1622 href="http://www.ncbi.nlm.nih.gov/pubmed/12471074">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1625 href="http://dx.doi.org/10.1164/rccm.2108069">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d28924e1634 class=n-a></a>Prakash YS, Halayko AJ, Gosens R, <i> et al.</i>: An Official American Thoracic Society Research Statement: Current Challenges Facing Research and Therapeutic Advances in Airway Remodeling. <i>Am J Respir Crit Care Med.</i> 2017; <b>195</b>(2): e4–e19. <a target=xrefwindow id=d28924e1645 href="http://www.ncbi.nlm.nih.gov/pubmed/28084822">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1648 href="http://dx.doi.org/10.1164/rccm.201611-2248ST">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d28924e1657 class=n-a></a>HUBER HL, KOESSLER KK: THE PATHOLOGY OF BRONCHIAL ASTHMA. <i>Arch Intern Med.</i> 1922; <b>30</b>: 689. <a target=xrefwindow id=d28924e1665 href="http://dx.doi.org/10.1001/archinte.1922.00110120002001">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d28924e1674 class=n-a></a>Kuwano K, Bosken CH, Paré PD, <i> et al.</i>: Small airways dimensions in asthma and in chronic obstructive pulmonary disease. <i>Am Rev Respir Dis.</i> 1993; <b>148</b>(5): 1220–5. <a target=xrefwindow id=d28924e1685 href="http://www.ncbi.nlm.nih.gov/pubmed/8239157">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1688 href="http://dx.doi.org/10.1164/ajrccm/148.5.1220">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d28924e1697 class=n-a></a>Halwani R, Al-Muhsen S, Hamid Q: Airway remodeling in asthma. <i>Curr Opin Pharmacol.</i> 2010; <b>10</b>(3): 236–45. <a target=xrefwindow id=d28924e1705 href="http://www.ncbi.nlm.nih.gov/pubmed/20591736">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1708 href="http://dx.doi.org/10.1016/j.coph.2010.06.004">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d28924e1718 class=n-a></a>Fahy JV: Remodeling of the airway epithelium in asthma. <i>Am J Respir Crit Care Med.</i> 2001; <b>164</b>(10 Pt 2): S46–51. <a target=xrefwindow id=d28924e1726 href="http://www.ncbi.nlm.nih.gov/pubmed/11734466">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1729 href="http://dx.doi.org/10.1164/ajrccm.164.supplement_2.2106066">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d28924e1738 class=n-a></a>Davies DE: The bronchial epithelium in chronic and severe asthma. <i>Curr Allergy Asthma Rep.</i> 2001; <b>1</b>(2): 127–33. <a target=xrefwindow id=d28924e1746 href="http://www.ncbi.nlm.nih.gov/pubmed/11899295">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1749 href="http://dx.doi.org/10.1007/s11882-001-0080-9">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d28924e1758 class=n-a></a>Holgate ST, Arshad HS, Roberts GC, <i> et al.</i>: A new look at the pathogenesis of asthma. <i>Clin Sci (Lond).</i> 2009; <b>118</b>(7): 439–50. <a target=xrefwindow id=d28924e1769 href="http://www.ncbi.nlm.nih.gov/pubmed/20025610">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1772 href="http://dx.doi.org/10.1042/CS20090474">Publisher Full Text </a> | <a target=xrefwindow id=d28924e1776 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2805922">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d28924e1785 class=n-a></a>Loxham M, Davies DE, Blume C: Epithelial function and dysfunction in asthma. <i>Clin Exp Allergy.</i> 2014; <b>44</b>(11): 1299–313. <a target=xrefwindow id=d28924e1793 href="http://www.ncbi.nlm.nih.gov/pubmed/24661647">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1796 href="http://dx.doi.org/10.1111/cea.12309">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d28924e1805 class=n-a></a>Lambrecht BN, Hammad H: The airway epithelium in asthma. <i>Nat Med.</i> 2012; <b>18</b>(5): 684–92. <a target=xrefwindow id=d28924e1813 href="http://www.ncbi.nlm.nih.gov/pubmed/22561832">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1816 href="http://dx.doi.org/10.1038/nm.2737">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d28924e1825 class=n-a></a>Erle DJ, Sheppard D: The cell biology of asthma. <i>J Cell Biol.</i> 2014; <b>205</b>(5): 621–31. <a target=xrefwindow id=d28924e1833 href="http://www.ncbi.nlm.nih.gov/pubmed/24914235">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1836 href="http://dx.doi.org/10.1083/jcb.201401050">Publisher Full Text </a> | <a target=xrefwindow id=d28924e1839 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4050726">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d28924e1849 class=n-a></a>Holgate ST: The airway epithelium is central to the pathogenesis of asthma. <i>Allergol Int.</i> 2008; <b>57</b>(1): 1–10. <a target=xrefwindow id=d28924e1857 href="http://www.ncbi.nlm.nih.gov/pubmed/18209502">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1860 href="http://dx.doi.org/10.2332/allergolint.R-07-154">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d28924e1869 class=n-a></a>Holgate ST: Pathogenesis of asthma. <i>Clin Exp Allergy.</i> 2008; <b>38</b>(6): 872–97. <a target=xrefwindow id=d28924e1877 href="http://www.ncbi.nlm.nih.gov/pubmed/18498538">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1880 href="http://dx.doi.org/10.1111/j.1365-2222.2008.02971.x">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d28924e1889 class=n-a></a>Sumi Y, Hamid Q: Airway remodeling in asthma. <i>Allergol Int.</i> 2007; <b>56</b>(4): 341–8. <a target=xrefwindow id=d28924e1897 href="http://www.ncbi.nlm.nih.gov/pubmed/17965577">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1900 href="http://dx.doi.org/10.2332/allergolint.R-07-153">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d28924e1909 class=n-a></a>Hirota JA, Hackett TL, Inman MD, <i> et al.</i>: Modeling asthma in mice: what have we learned about the airway epithelium? <i>Am J Respir Cell Mol Biol.</i> 2011; <b>44</b>(4): 431–8. <a target=xrefwindow id=d28924e1920 href="http://www.ncbi.nlm.nih.gov/pubmed/20724554">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1923 href="http://dx.doi.org/10.1165/rcmb.2010-0146TR">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d28924e1932 class=n-a></a>Bossé Y, Paré PD, Seow CY: Airway wall remodeling in asthma: from the epithelial layer to the adventitia. <i>Curr Allergy Asthma Rep.</i> 2008; <b>8</b>(4): 357–66. <a target=xrefwindow id=d28924e1940 href="http://www.ncbi.nlm.nih.gov/pubmed/18606090">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1943 href="http://dx.doi.org/10.1007/s11882-008-0056-0">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d28924e1952 class=n-a></a>Proud D, Leigh R: Epithelial cells and airway diseases. <i>Immunol Rev.</i> 2011; <b>242</b>(1): 186–204. <a target=xrefwindow id=d28924e1960 href="http://www.ncbi.nlm.nih.gov/pubmed/21682746">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1963 href="http://dx.doi.org/10.1111/j.1600-065X.2011.01033.x">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d28924e1973 class=n-a></a>Aikawa T, Shimura S, Sasaki H, <i> et al.</i>: Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. <i>Chest.</i> 1992; <b>101</b>(4): 916–21. <a target=xrefwindow id=d28924e1984 href="http://www.ncbi.nlm.nih.gov/pubmed/1555462">PubMed Abstract </a> | <a target=xrefwindow id=d28924e1987 href="http://dx.doi.org/10.1378/chest.101.4.916">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d28924e1996 class=n-a></a>Kim KC, McCracken K, Lee BC, <i> et al.</i>: Airway goblet cell mucin: its structure and regulation of secretion. <i>Eur Respir J.</i> 1997; <b>10</b>(11): 2644–9. <a target=xrefwindow id=d28924e2007 href="http://www.ncbi.nlm.nih.gov/pubmed/9426108">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2010 href="http://dx.doi.org/10.1183/09031936.97.10112644">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727180654"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e2019 class=n-a></a>Pascoe CD, Seow CY, Hackett TL, <i> et al.</i>: Heterogeneity of airway wall dimensions in humans: a critical determinant of lung function in asthmatics and nonasthmatics. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2017; <b>312</b>(3): L425–L431. <a target=xrefwindow id=d28924e2030 href="http://www.ncbi.nlm.nih.gov/pubmed/28062484">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2033 href="http://dx.doi.org/10.1152/ajplung.00421.2016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727180654">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d28924e2046 class=n-a></a>Prakash YS: Airway smooth muscle in airway reactivity and remodeling: what have we learned? <i>Am J Physiol Lung Cell Mol Physiol.</i> 2013; <b>305</b>(12): L912–33. <a target=xrefwindow id=d28924e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/24142517">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2057 href="http://dx.doi.org/10.1152/ajplung.00259.2013">Publisher Full Text </a> | <a target=xrefwindow id=d28924e2060 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3882535">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d28924e2069 class=n-a></a>Gosens R, Grainge C: Bronchoconstriction and airway biology: potential impact and therapeutic opportunities. <i>Chest.</i> 2015; <b>147</b>(3): 798–803. <a target=xrefwindow id=d28924e2077 href="http://www.ncbi.nlm.nih.gov/pubmed/25732446">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2080 href="http://dx.doi.org/10.1378/chest.14-1142">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d28924e2089 class=n-a></a>Noble PB, Pascoe CD, Lan B, <i> et al.</i>: Airway smooth muscle in asthma: linking contraction and mechanotransduction to disease pathogenesis and remodelling. <i>Pulm Pharmacol Ther.</i> 2014; <b>29</b>(2): 96–107. <a target=xrefwindow id=d28924e2100 href="http://www.ncbi.nlm.nih.gov/pubmed/25062835">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2103 href="http://dx.doi.org/10.1016/j.pupt.2014.07.005">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d28924e2113 class=n-a></a>Johnson PR: Role of human airway smooth muscle in altered extracellular matrix production in asthma. <i>Clin Exp Pharmacol Physiol.</i> 2001; <b>28</b>(3): 233–6. <a target=xrefwindow id=d28924e2121 href="http://www.ncbi.nlm.nih.gov/pubmed/11236132">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2124 href="http://dx.doi.org/10.1046/j.1440-1681.2001.03426.x">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d28924e2133 class=n-a></a>Johnson PR, Burgess JK: Airway smooth muscle and fibroblasts in the pathogenesis of asthma. <i>Curr Allergy Asthma Rep.</i> 2004; <b>4</b>(2): 102–8. <a target=xrefwindow id=d28924e2141 href="http://www.ncbi.nlm.nih.gov/pubmed/14769258">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2144 href="http://dx.doi.org/10.1007/s11882-004-0054-9">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d28924e2153 class=n-a></a>Panettieri RA Jr: Airway smooth muscle: an immunomodulatory cell. <i>J Allergy Clin Immunol.</i> 2002; <b>110</b>(6 Suppl): S269–74. <a target=xrefwindow id=d28924e2161 href="http://www.ncbi.nlm.nih.gov/pubmed/12464935">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2164 href="http://dx.doi.org/10.1067/mai.2002.129429">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d28924e2173 class=n-a></a>Chakir J, Haj-Salem I, Gras D, <i> et al.</i>: Effects of Bronchial Thermoplasty on Airway Smooth Muscle and Collagen Deposition in Asthma. <i>Ann Am Thorac Soc.</i> 2015; <b>12</b>(11): 1612–8. <a target=xrefwindow id=d28924e2184 href="http://www.ncbi.nlm.nih.gov/pubmed/26325484">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2187 href="http://dx.doi.org/10.1513/AnnalsATS.201504-208OC">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d28924e2196 class=n-a></a>Pain M, Bermudez O, Lacoste P, <i> et al.</i>: Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. <i>Eur Respir Rev.</i> 2014; <b>23</b>(131): 118–30. <a target=xrefwindow id=d28924e2207 href="http://www.ncbi.nlm.nih.gov/pubmed/24591669">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2210 href="http://dx.doi.org/10.1183/09059180.00004413">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726028213"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e2219 class=n-a></a>Ball SL, Mann DA, Wilson JA, <i> et al.</i>: The Role of the Fibroblast in Inflammatory Upper Airway Conditions. <i>Am J Pathol.</i> 2016; <b>186</b>(2): 225–33. <a target=xrefwindow id=d28924e2230 href="http://www.ncbi.nlm.nih.gov/pubmed/26687989">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2233 href="http://dx.doi.org/10.1016/j.ajpath.2015.09.020">Publisher Full Text </a> | <a target=xrefwindow id=d28924e2237 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4729240">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726028213">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d28924e2251 class=n-a></a>Bonacci JV, Stewart AG: Regulation of human airway mesenchymal cell proliferation by glucocorticoids and beta<sub>2</sub>-adrenoceptor agonists. <i>Pulm Pharmacol Ther.</i> 2006; <b>19</b>(1): 32–8. <a target=xrefwindow id=d28924e2262 href="http://www.ncbi.nlm.nih.gov/pubmed/16286235">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2265 href="http://dx.doi.org/10.1016/j.pupt.2005.02.011">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d28924e2274 class=n-a></a>Girodet PO, Ozier A, Bara I, <i> et al.</i>: Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. <i>Pharmacol Ther.</i> 2011; <b>130</b>(3): 325–37. <a target=xrefwindow id=d28924e2285 href="http://www.ncbi.nlm.nih.gov/pubmed/21334378">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2288 href="http://dx.doi.org/10.1016/j.pharmthera.2011.02.001">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d28924e2297 class=n-a></a>Hassan M, Jo T, Risse PA, <i> et al.</i>: Airway smooth muscle remodeling is a dynamic process in severe long-standing asthma. <i>J Allergy Clin Immunol.</i> 2010; <b>125</b>(5): 1037–1045.e3. <a target=xrefwindow id=d28924e2308 href="http://www.ncbi.nlm.nih.gov/pubmed/20451038">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2311 href="http://dx.doi.org/10.1016/j.jaci.2010.02.031">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d28924e2320 class=n-a></a>Mitsunobu F, Tanizaki Y: The use of computed tomography to assess asthma severity. <i>Curr Opin Allergy Clin Immunol.</i> 2005; <b>5</b>(1): 85–90. <a target=xrefwindow id=d28924e2328 href="http://www.ncbi.nlm.nih.gov/pubmed/15643349">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2331 href="http://dx.doi.org/10.1097/00130832-200502000-00015">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d28924e2340 class=n-a></a>Bai TR: Evidence for airway remodeling in chronic asthma. <i>Curr Opin Allergy Clin Immunol.</i> 2010; <b>10</b>(1): 82–6. <a target=xrefwindow id=d28924e2348 href="http://www.ncbi.nlm.nih.gov/pubmed/19858714">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2351 href="http://dx.doi.org/10.1097/ACI.0b013e32833363b2">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d28924e2360 class=n-a></a>Yamauchi K: Airway remodeling in asthma and its influence on clinical pathophysiology. <i>Tohoku J Exp Med.</i> 2006; <b>209</b>(2): 75–87. <a target=xrefwindow id=d28924e2368 href="http://www.ncbi.nlm.nih.gov/pubmed/16707849">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2371 href="http://dx.doi.org/10.1620/tjem.209.75">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d28924e2381 class=n-a></a>Niimi A, Matsumoto H, Takemura M, <i> et al.</i>: Clinical assessment of airway remodeling in asthma: utility of computed tomography. <i>Clin Rev Allergy Immunol.</i> 2004; <b>27</b>(1): 45–58. <a target=xrefwindow id=d28924e2392 href="http://www.ncbi.nlm.nih.gov/pubmed/15347850">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2395 href="http://dx.doi.org/10.1385/CRIAI:27:1:045">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d28924e2404 class=n-a></a>Aysola R, de Lange EE, Castro M, <i> et al.</i>: Demonstration of the heterogeneous distribution of asthma in the lungs using CT and hyperpolarized helium-3 MRI. <i>J Magn Reson Imaging.</i> 2010; <b>32</b>(6): 1379–87. <a target=xrefwindow id=d28924e2415 href="http://www.ncbi.nlm.nih.gov/pubmed/21105142">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2418 href="http://dx.doi.org/10.1002/jmri.22388">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d28924e2427 class=n-a></a>Montaudon M, Lederlin M, Reich S, <i> et al.</i>: Bronchial measurements in patients with asthma: comparison of quantitative thin-section CT findings with those in healthy subjects and correlation with pathologic findings. <i>Radiology.</i> 2009; <b>253</b>(3): 844–53. <a target=xrefwindow id=d28924e2438 href="http://www.ncbi.nlm.nih.gov/pubmed/19789219">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2441 href="http://dx.doi.org/10.1148/radiol.2533090303">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1072703"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e2450 class=n-a></a>Cox G, Thomson NC, Rubin AS, <i> et al.</i>: Asthma control during the year after bronchial thermoplasty. <i>N Engl J Med.</i> 2007; <b>356</b>(13): 1327–37. <a target=xrefwindow id=d28924e2461 href="http://www.ncbi.nlm.nih.gov/pubmed/17392302">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2464 href="http://dx.doi.org/10.1056/NEJMoa064707">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1072703">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d28924e2477 class=n-a></a>Pavord ID, Cox G, Thomson NC, <i> et al.</i>: Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. <i>Am J Respir Crit Care Med.</i> 2007; <b>176</b>(12): 1185–91. <a target=xrefwindow id=d28924e2488 href="http://www.ncbi.nlm.nih.gov/pubmed/17901415">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2491 href="http://dx.doi.org/10.1164/rccm.200704-571OC">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d28924e2500 class=n-a></a>Wahidi MM, Kraft M: Bronchial thermoplasty for severe asthma. <i>Am J Respir Crit Care Med.</i> 2012; <b>185</b>(7): 709–14. <a target=xrefwindow id=d28924e2508 href="http://www.ncbi.nlm.nih.gov/pubmed/22077066">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2511 href="http://dx.doi.org/10.1164/rccm.201105-0883CI">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725301281"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e2521 class=n-a></a>Trian T, Allard B, Dupin I, <i> et al.</i>: House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway. <i>Am J Respir Crit Care Med.</i> 2015; <b>191</b>(5): 538–46. <a target=xrefwindow id=d28924e2532 href="http://www.ncbi.nlm.nih.gov/pubmed/25569771">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2535 href="http://dx.doi.org/10.1164/rccm.201409-1582OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725301281">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11121956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e2548 class=n-a></a>Grainge CL, Lau LC, Ward JA, <i> et al.</i>: Effect of bronchoconstriction on airway remodeling in asthma. <i>N Engl J Med.</i> 2011; <b>364</b>(21): 2006–15. <a target=xrefwindow id=d28924e2559 href="http://www.ncbi.nlm.nih.gov/pubmed/21612469">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2562 href="http://dx.doi.org/10.1056/NEJMoa1014350">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11121956">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d28924e2575 class=n-a></a>Kistemaker LE, Oenema TA, Meurs H, <i> et al.</i>: Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. <i>Life Sci.</i> 2012; <b>91</b>(21-22): 1126–33. <a target=xrefwindow id=d28924e2586 href="http://www.ncbi.nlm.nih.gov/pubmed/22406302">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2589 href="http://dx.doi.org/10.1016/j.lfs.2012.02.021">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1048162"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e2598 class=n-a></a>Henderson WR Jr, Chiang GK, Tien YT, <i> et al.</i>: Reversal of allergen-induced airway remodeling by CysLT<sub>1</sub> receptor blockade. <i>Am J Respir Crit Care Med.</i> 2006; <b>173</b>(7): 718–28. <a target=xrefwindow id=d28924e2612 href="http://www.ncbi.nlm.nih.gov/pubmed/16387808">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2616 href="http://dx.doi.org/10.1164/rccm.200501-088OC">Publisher Full Text </a> | <a target=xrefwindow id=d28924e2619 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2662952">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1048162">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d28924e2632 class=n-a></a>Muz MH, Deveci F, Bulut Y, <i> et al.</i>: The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model. <i>Exp Mol Med.</i> 2006; <b>38</b>(2): 109–18. <a target=xrefwindow id=d28924e2643 href="http://www.ncbi.nlm.nih.gov/pubmed/16672764">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2646 href="http://dx.doi.org/10.1038/emm.2006.14">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d28924e2655 class=n-a></a>Kelly MM, Chakir J, Vethanayagam D, <i> et al.</i>: Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. <i>Chest.</i> 2006; <b>130</b>(3): 741–53. <a target=xrefwindow id=d28924e2666 href="http://www.ncbi.nlm.nih.gov/pubmed/16963671">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2669 href="http://dx.doi.org/10.1378/chest.130.3.741">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d28924e2679 class=n-a></a>Gosens R, Bos IS, Zaagsma J, <i> et al.</i>: Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. <i>Am J Respir Crit Care Med.</i> 2005; <b>171</b>(10): 1096–102. <a target=xrefwindow id=d28924e2690 href="http://www.ncbi.nlm.nih.gov/pubmed/15695490">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2693 href="http://dx.doi.org/10.1164/rccm.200409-1249OC">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d28924e2702 class=n-a></a>Pera T, Zuidhof A, Valadas J, <i> et al.</i>: Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. <i>Eur Respir J.</i> 2011; <b>38</b>(4): 789–96. <a target=xrefwindow id=d28924e2713 href="http://www.ncbi.nlm.nih.gov/pubmed/21349917">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2716 href="http://dx.doi.org/10.1183/09031936.00146610">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d28924e2725 class=n-a></a>Ohta S, Oda N, Yokoe T, <i> et al.</i>: Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. <i>Clin Exp Allergy.</i> 2010; <b>40</b>(8): 1266–75. <a target=xrefwindow id=d28924e2736 href="http://www.ncbi.nlm.nih.gov/pubmed/20337647">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2739 href="http://dx.doi.org/10.1111/j.1365-2222.2010.03478.x">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d28924e2748 class=n-a></a>Kang JY, Rhee CK, Kim JS, <i> et al.</i>: Effect of tiotropium bromide on airway remodeling in a chronic asthma model. <i>Ann Allergy Asthma Immunol.</i> 2012; <b>109</b>(1): 29–35. <a target=xrefwindow id=d28924e2759 href="http://www.ncbi.nlm.nih.gov/pubmed/22727154 ">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2762 href="http://dx.doi.org/10.1016/j.anai.2012.05.005">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d28924e2771 class=n-a></a>Bos IS, Gosens R, Zuidhof AB, <i> et al.</i>: Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. <i>Eur Respir J.</i> 2007; <b>30</b>(4): 653–61. <a target=xrefwindow id=d28924e2782 href="http://www.ncbi.nlm.nih.gov/pubmed/17537779">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2785 href="http://dx.doi.org/10.1183/09031936.00004907">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d28924e2794 class=n-a></a>Levine SJ, Larivée P, Logun C, <i> et al.</i>: Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. <i>Am J Physiol.</i> 1993; <b>265</b>(4 Pt 1): L360–8. <a target=xrefwindow id=d28924e2805 href="http://www.ncbi.nlm.nih.gov/pubmed/7694480">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2808 href="http://dx.doi.org/10.1152/ajplung.1993.265.4.L360">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d28924e2818 class=n-a></a>Dorscheid DR, Wojcik KR, Sun S, <i> et al.</i>: Apoptosis of airway epithelial cells induced by corticosteroids. <i>Am J Respir Crit Care Med.</i> 2001; <b>164</b>(10 Pt 1): 1939–47. <a target=xrefwindow id=d28924e2829 href="http://www.ncbi.nlm.nih.gov/pubmed/11734450">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2832 href="http://dx.doi.org/10.1164/ajrccm.164.10.2103013">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d28924e2841 class=n-a></a>Sabatini F, Silvestri M, Sale R, <i> et al.</i>: Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling. <i>Pulm Pharmacol Ther.</i> 2003; <b>16</b>(5): 287–97. <a target=xrefwindow id=d28924e2852 href="http://www.ncbi.nlm.nih.gov/pubmed/12877820">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2855 href="http://dx.doi.org/10.1016/S1094-5539(03)00068-3">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d28924e2864 class=n-a></a>Descalzi D, Folli C, Nicolini G, <i> et al.</i>: Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts. <i>Allergy.</i> 2008; <b>63</b>(4): 432–7. <a target=xrefwindow id=d28924e2875 href="http://www.ncbi.nlm.nih.gov/pubmed/18076728">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2878 href="http://dx.doi.org/10.1111/j.1398-9995.2007.01582.x">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d28924e2887 class=n-a></a>Young PG, Skinner SJ, Black PN: Effects of glucocorticoids and beta-adrenoceptor agonists on the proliferation of airway smooth muscle. <i>Eur J Pharmacol.</i> 1995; <b>273</b>(1–2): 137–43. <a target=xrefwindow id=d28924e2895 href="http://www.ncbi.nlm.nih.gov/pubmed/7737307">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2898 href="http://dx.doi.org/10.1016/0014-2999(94)00679-2">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d28924e2907 class=n-a></a>Stewart AG, Fernandes D, Tomlinson PR: The effect of glucocorticoids on proliferation of human cultured airway smooth muscle. <i>Br J Pharmacol.</i> 1995; <b>116</b>(8): 3219–26. <a target=xrefwindow id=d28924e2915 href="http://www.ncbi.nlm.nih.gov/pubmed/8719799">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2918 href="http://dx.doi.org/10.1111/j.1476-5381.1995.tb15127.x">Publisher Full Text </a> | <a target=xrefwindow id=d28924e2921 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1909167">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d28924e2930 class=n-a></a>Damera G, Fogle HW, Lim P, <i> et al.</i>: Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. <i>Br J Pharmacol.</i> 2009; <b>158</b>(6): 1429–41. <a target=xrefwindow id=d28924e2941 href="http://www.ncbi.nlm.nih.gov/pubmed/19814732">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2944 href="http://dx.doi.org/10.1111/j.1476-5381.2009.00428.x">Publisher Full Text </a> | <a target=xrefwindow id=d28924e2948 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2795210">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d28924e2958 class=n-a></a>Perry MM, Baker JE, Gibeon DS, <i> et al.</i>: Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma. <i>Am J Respir Cell Mol Biol.</i> 2014; <b>50</b>(1): 7–17. <a target=xrefwindow id=d28924e2969 href="http://www.ncbi.nlm.nih.gov/pubmed/23944957">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2972 href="http://dx.doi.org/10.1165/rcmb.2013-0067OC">Publisher Full Text </a> | <a target=xrefwindow id=d28924e2976 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3930931">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d28924e2985 class=n-a></a>Ward C, Reid DW, Orsida BE, <i> et al.</i>: Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis. <i>Clin Exp Allergy.</i> 2005; <b>35</b>(12): 1565–71. <a target=xrefwindow id=d28924e2996 href="http://www.ncbi.nlm.nih.gov/pubmed/16393322">PubMed Abstract </a> | <a target=xrefwindow id=d28924e2999 href="http://dx.doi.org/10.1111/j.1365-2222.2005.02365.x">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d28924e3008 class=n-a></a>Bergeron C, Tulic MK, Hamid Q: Airway remodelling in asthma: from benchside to clinical practice. <i>Can Respir J.</i> 2010; <b>17</b>(4): e85–93. <a target=xrefwindow id=d28924e3016 href="http://www.ncbi.nlm.nih.gov/pubmed/20808979">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3019 href="http://dx.doi.org/10.1155/2010/318029">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3022 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2933777">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d28924e3031 class=n-a></a>Laitinen A, Altraja A, Kämpe M, <i> et al.</i>: Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. <i>Am J Respir Crit Care Med.</i> 1997; <b>156</b>(3 Pt 1): 951–8. <a target=xrefwindow id=d28924e3042 href="http://www.ncbi.nlm.nih.gov/pubmed/9310019">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3045 href="http://dx.doi.org/10.1164/ajrccm.156.3.9610084">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d28924e3054 class=n-a></a>Laitinen LA, Laitinen A: Inhaled corticosteroid treatment for asthma. <i>Allergy Proc.</i> 1995; <b>16</b>(2): 63–6. <a target=xrefwindow id=d28924e3062 href="http://www.ncbi.nlm.nih.gov/pubmed/7797060">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3065 href="http://dx.doi.org/10.1002/9780470987377.ch12">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d28924e3074 class=n-a></a>Boulet LP, Turcotte H, Laviolette M, <i> et al.</i>: Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. <i>Am J Respir Crit Care Med.</i> 2000; <b>162</b>(4 Pt 1): 1308–13. <a target=xrefwindow id=d28924e3085 href="http://www.ncbi.nlm.nih.gov/pubmed/11029336">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3088 href="http://dx.doi.org/10.1164/ajrccm.162.4.9910051">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d28924e3098 class=n-a></a>Olivieri D, Chetta A, Del Donno M, <i> et al.</i>: Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. <i>Am J Respir Crit Care Med.</i> 1997; <b>155</b>(6): 1864–71. <a target=xrefwindow id=d28924e3109 href="http://www.ncbi.nlm.nih.gov/pubmed/9196087">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3112 href="http://dx.doi.org/10.1164/ajrccm.155.6.9196087">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d28924e3121 class=n-a></a>Trigg CJ, Manolitsas ND, Wang J, <i> et al.</i>: Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. <i>Am J Respir Crit Care Med.</i> 1994; <b>150</b>(1): 17–22. <a target=xrefwindow id=d28924e3132 href="http://www.ncbi.nlm.nih.gov/pubmed/8025745">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3135 href="http://dx.doi.org/10.1164/ajrccm.150.1.8025745">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d28924e3144 class=n-a></a>Hoshino M, Takahashi M, Takai Y, <i> et al.</i>: Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. <i>J Allergy Clin Immunol.</i> 1999; <b>104</b>(2 Pt 1): 356–63. <a target=xrefwindow id=d28924e3155 href="http://www.ncbi.nlm.nih.gov/pubmed/10452757">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3158 href="http://dx.doi.org/10.1016/S0091-6749(99)70379-9">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d28924e3167 class=n-a></a>Sont JK, Willems LN, Bel EH, <i> et al.</i>: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. <i>Am J Respir Crit Care Med.</i> 1999; <b>159</b>(4 Pt 1): 1043–51. <a target=xrefwindow id=d28924e3178 href="http://www.ncbi.nlm.nih.gov/pubmed/10194144">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3181 href="http://dx.doi.org/10.1164/ajrccm.159.4.9806052">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d28924e3190 class=n-a></a>Chakir J, Shannon J, Molet S, <i> et al.</i>: Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. <i>J Allergy Clin Immunol.</i> 2003; <b>111</b>(6): 1293–8. <a target=xrefwindow id=d28924e3201 href="http://www.ncbi.nlm.nih.gov/pubmed/12789232">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3204 href="http://dx.doi.org/10.1067/mai.2003.1557">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d28924e3213 class=n-a></a>Orsida BE, Li X, Hickey B, <i> et al.</i>: Vascularity in asthmatic airways: relation to inhaled steroid dose. <i>Thorax.</i> 1999; <b>54</b>(4): 289–95. <a target=xrefwindow id=d28924e3224 href="http://www.ncbi.nlm.nih.gov/pubmed/10092688">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3227 href="http://dx.doi.org/10.1136/thx.54.4.289">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3231 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1745476">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d28924e3241 class=n-a></a>Belvisi MG, Saunders M, Yacoub M, <i> et al.</i>: Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth. <i>Br J Pharmacol.</i> 1998; <b>125</b>(5): 1102–8. <a target=xrefwindow id=d28924e3252 href="http://www.ncbi.nlm.nih.gov/pubmed/9846651">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3255 href="http://dx.doi.org/10.1038/sj.bjp.0702104">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3259 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1565660">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d28924e3268 class=n-a></a>Misior AM, Yan H, Pascual RM, <i> et al.</i>: Mitogenic effects of cytokines on smooth muscle are critically dependent on protein kinase A and are unmasked by steroids and cyclooxygenase inhibitors. <i>Mol Pharmacol.</i> 2008; <b>73</b>(2): 566–74. <a target=xrefwindow id=d28924e3279 href="http://www.ncbi.nlm.nih.gov/pubmed/17993511">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3282 href="http://dx.doi.org/10.1124/mol.107.040519">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d28924e3291 class=n-a></a>Yan H, Deshpande DA, Misior AM, <i> et al.</i>: Anti-mitogenic effects of β-agonists and PGE<sub>2</sub> on airway smooth muscle are PKA dependent. <i>FASEB J.</i> 2011; <b>25</b>(1): 389–97. <a target=xrefwindow id=d28924e3305 href="http://www.ncbi.nlm.nih.gov/pubmed/20805374">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3309 href="http://dx.doi.org/10.1096/fj.10-164798">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3312 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3005432">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d28924e3321 class=n-a></a>Kawakami Y, Uchiyama K, Irie T, <i> et al.</i>: Evaluation of aerosols of prostaglandins E<sub>1</sub> and E<sub>2</sub> as bronchodilators. <i>Eur J Clin Pharmacol.</i> 1973; <b>6</b>(2): 127–32. <a target=xrefwindow id=d28924e3339 href="http://www.ncbi.nlm.nih.gov/pubmed/4588852">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3342 href="http://dx.doi.org/10.1007/BF00562439">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d28924e3351 class=n-a></a>Walters EH, Davies BH: Dual effect of prostaglandin E<sub>2 </sub>on normal airways smooth muscle <i>in vivo</i>. <i>Thorax.</i> 1982; <b>37</b>(12): 918–22. <a target=xrefwindow id=d28924e3365 href="http://www.ncbi.nlm.nih.gov/pubmed/6221430">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3369 href="http://dx.doi.org/10.1136/thx.37.12.918">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3372 href="http://www.ncbi.nlm.nih.gov/pmc/articles/459458">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d28924e3381 class=n-a></a>Costello JF, Dunlop LS, Gardiner PJ: Characteristics of prostaglandin induced cough in man. <i>Br J Clin Pharmacol.</i> 1985; <b>20</b>(4): 355–9. <a target=xrefwindow id=d28924e3389 href="http://www.ncbi.nlm.nih.gov/pubmed/3865687">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3392 href="http://dx.doi.org/10.1111/j.1365-2125.1985.tb05077.x">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3395 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1400874">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d28924e3405 class=n-a></a>Coleridge HM, Coleridge JC, Ginzel KH, <i> et al.</i>: Stimulation of 'irritant' receptors and afferent C-fibres in the lungs by prostaglandins. <i>Nature.</i> 1976; <b>264</b>(5585): 451–3. <a target=xrefwindow id=d28924e3416 href="http://www.ncbi.nlm.nih.gov/pubmed/1004577">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3419 href="http://dx.doi.org/10.1038/264451a0">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d28924e3428 class=n-a></a>Gauvreau GM, Watson RM, O'Byrne PM: Protective effects of inhaled PGE<sub>2</sub> on allergen-induced airway responses and airway inflammation. <i>Am J Respir Crit Care Med.</i> 1999; <b>159</b>(1): 31–6. <a target=xrefwindow id=d28924e3439 href="http://www.ncbi.nlm.nih.gov/pubmed/9872814">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3442 href="http://dx.doi.org/10.1164/ajrccm.159.1.9804030">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d28924e3451 class=n-a></a>Maher SA, Birrell MA, Belvisi MG: Prostaglandin E<sub>2</sub> mediates cough via the EP<sub>3</sub> receptor: implications for future disease therapy. <i>Am J Respir Crit Care Med.</i> 2009; <b>180</b>(10): 923–8. <a target=xrefwindow id=d28924e3465 href="http://www.ncbi.nlm.nih.gov/pubmed/19729667">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3469 href="http://dx.doi.org/10.1164/rccm.200903-0388OC">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3472 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2778154">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d28924e3481 class=n-a></a>Sharma P, Panebra A, Pera T, <i> et al.</i>: Antimitogenic effect of bitter taste receptor agonists on airway smooth muscle cells. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2016; <b>310</b>(4): L365–76. <a target=xrefwindow id=d28924e3492 href="http://www.ncbi.nlm.nih.gov/pubmed/26684251">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3495 href="http://dx.doi.org/10.1152/ajplung.00373.2015">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3499 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4754903">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d28924e3508 class=n-a></a>Pan S, Sharma P, Shah SD, <i> et al.</i>: Bitter taste receptor agonists alter mitochondrial function and induce autophagy in airway smooth muscle cells. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2017; <b>313</b>(1): L154–L165. <a target=xrefwindow id=d28924e3519 href="http://www.ncbi.nlm.nih.gov/pubmed/28450286">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3522 href="http://dx.doi.org/10.1152/ajplung.00106.2017">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3526 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5538869">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d28924e3535 class=n-a></a>Sharma P, Yi R, Nayak AP, <i> et al.</i>: Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice. <i>Sci Rep.</i> 2017; <b>7</b>: 46166. <a target=xrefwindow id=d28924e3546 href="http://www.ncbi.nlm.nih.gov/pubmed/28397820">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3549 href="http://dx.doi.org/10.1038/srep46166">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3553 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5387415">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d28924e3563 class=n-a></a>Pera T, Penn RB: Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones. <i>Pharmacol Ther.</i> 2016; <b>164</b>: 82–96. <a target=xrefwindow id=d28924e3571 href="http://www.ncbi.nlm.nih.gov/pubmed/27113408">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3574 href="http://dx.doi.org/10.1016/j.pharmthera.2016.04.002">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3577 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4942340">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d28924e3586 class=n-a></a>Flood-Page P, Menzies-Gow A, Phipps S, <i> et al.</i>: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. <i>J Clin Invest.</i> 2003; <b>112</b>(7): 1029–36. <a target=xrefwindow id=d28924e3597 href="http://www.ncbi.nlm.nih.gov/pubmed/14523040">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3600 href="http://dx.doi.org/10.1172/JCI17974">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3604 href="http://www.ncbi.nlm.nih.gov/pmc/articles/198522">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d28924e3613 class=n-a></a>Blyth DI, Wharton TF, Pedrick MS, <i> et al.</i>: Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. <i>Am J Respir Cell Mol Biol.</i> 2000; <b>23</b>(2): 241–6. <a target=xrefwindow id=d28924e3624 href="http://www.ncbi.nlm.nih.gov/pubmed/10919992">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3627 href="http://dx.doi.org/10.1165/ajrcmb.23.2.3999">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727436785"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e3636 class=n-a></a>Riccio AM, Mauri P, De Ferrari L, <i> et al.</i>: Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months. <i>Clin Transl Allergy.</i> 2017; <b>7</b>: 6. <a target=xrefwindow id=d28924e3647 href="http://www.ncbi.nlm.nih.gov/pubmed/28293414">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3650 href="http://dx.doi.org/10.1186/s13601-017-0143-1">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3654 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5345272">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727436785">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d28924e3667 class=n-a></a>Li N, Li Q, Zhou XD, <i> et al.</i>: Chronic mechanical stress induces mucin 5AC expression in human bronchial epithelial cells through ERK dependent pathways. <i>Mol Biol Rep.</i> 2012; <b>39</b>(2): 1019–28. <a target=xrefwindow id=d28924e3678 href="http://www.ncbi.nlm.nih.gov/pubmed/21556755">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3681 href="http://dx.doi.org/10.1007/s11033-011-0827-x">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d28924e3690 class=n-a></a>Shinkai M, López-Boado YS, Rubin BK: Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by <i>Pseudomonas aeruginosa</i> flagellin. <i>J Antimicrob Chemother.</i> 2007; <b>59</b>(6): 1096–101. <a target=xrefwindow id=d28924e3701 href="http://www.ncbi.nlm.nih.gov/pubmed/17412724">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3704 href="http://dx.doi.org/10.1093/jac/dkm084">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d28924e3714 class=n-a></a>Nath P, Leung SY, Williams A, <i> et al.</i>: Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. <i>Eur J Pharmacol.</i> 2006; <b>544</b>(1–3): 160–7. <a target=xrefwindow id=d28924e3725 href="http://www.ncbi.nlm.nih.gov/pubmed/16843456">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3728 href="http://dx.doi.org/10.1016/j.ejphar.2006.06.031">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d28924e3737 class=n-a></a>Nath P, Eynott P, Leung SY, <i> et al.</i>: Potential role of c-Jun NH<sub>2</sub>-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. <i>Eur J Pharmacol.</i> 2005; <b>506</b>(3): 273–83. <a target=xrefwindow id=d28924e3751 href="http://www.ncbi.nlm.nih.gov/pubmed/15627438">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3755 href="http://dx.doi.org/10.1016/j.ejphar.2004.11.040">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d28924e3764 class=n-a></a>Wu H, Fang L, Shen QY, <i> et al.</i>: SP600125 promotes resolution of allergic airway inflammation via TLR9 in an OVA-induced murine acute asthma model. <i>Mol Immunol.</i> 2015; <b>67</b>(2 Pt B): 311–6. <a target=xrefwindow id=d28924e3775 href="http://www.ncbi.nlm.nih.gov/pubmed/26139014">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3778 href="http://dx.doi.org/10.1016/j.molimm.2015.06.016">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d28924e3787 class=n-a></a>Eynott PR, Nath P, Leung SY, <i> et al.</i>: Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N-terminal kinase. <i>Br J Pharmacol.</i> 2003; <b>140</b>(8): 1373–80. <a target=xrefwindow id=d28924e3798 href="http://www.ncbi.nlm.nih.gov/pubmed/14623764">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3801 href="http://dx.doi.org/10.1038/sj.bjp.0705569">Publisher Full Text </a> | <a target=xrefwindow id=d28924e3805 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1574155">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d28924e3814 class=n-a></a>Pera T, Atmaj C, van der Vegt M, <i> et al.</i>: Role for TAK1 in cigarette smoke-induced proinflammatory signaling and IL-8 release by human airway smooth muscle cells. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2012; <b>303</b>(3): L272–8. <a target=xrefwindow id=d28924e3825 href="http://www.ncbi.nlm.nih.gov/pubmed/22523282">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3828 href="http://dx.doi.org/10.1152/ajplung.00291.2011">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d28924e3837 class=n-a></a>Pera T, Sami R, Zaagsma J, <i> et al.</i>: TAK1 plays a major role in growth factor-induced phenotypic modulation of airway smooth muscle. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2011; <b>301</b>(5): L822–8. <a target=xrefwindow id=d28924e3848 href="http://www.ncbi.nlm.nih.gov/pubmed/21873447">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3851 href="http://dx.doi.org/10.1152/ajplung.00017.2011">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d28924e3861 class=n-a></a>Krymskaya VP, Orsini MJ, Eszterhas AJ, <i> et al.</i>: Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. <i>Am J Respir Cell Mol Biol.</i> 2000; <b>23</b>(4): 546–54. <a target=xrefwindow id=d28924e3872 href="http://www.ncbi.nlm.nih.gov/pubmed/11017921">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3875 href="http://dx.doi.org/10.1165/ajrcmb.23.4.4115">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d28924e3884 class=n-a></a>Puddicombe SM, Polosa R, Richter A, <i> et al.</i>: Involvement of the epidermal growth factor receptor in epithelial repair in asthma. <i>FASEB J.</i> 2000; <b>14</b>(10): 1362–74. <a target=xrefwindow id=d28924e3895 href="http://www.ncbi.nlm.nih.gov/pubmed/10877829">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3898 href="http://dx.doi.org/10.1096/fj.14.10.1362">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d28924e3907 class=n-a></a>Booth BW, Adler KB, Bonner JC, <i> et al.</i>: Interleukin-13 induces proliferation of human airway epithelial cells <i>in vitro</i> via a mechanism mediated by transforming growth factor-alpha. <i>Am J Respir Cell Mol Biol.</i> 2001; <b>25</b>(6): 739–43. <a target=xrefwindow id=d28924e3921 href="http://www.ncbi.nlm.nih.gov/pubmed/11726400">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3925 href="http://dx.doi.org/10.1165/ajrcmb.25.6.4659">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d28924e3934 class=n-a></a>Hegab AE, Sakamoto T, Nomura A, <i> et al.</i>: Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1. <i>Chest.</i> 2007; <b>131</b>(4): 1149–56. <a target=xrefwindow id=d28924e3945 href="http://www.ncbi.nlm.nih.gov/pubmed/17426222">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3948 href="http://dx.doi.org/10.1378/chest.06-2031">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726147139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e3957 class=n-a></a>Takezawa K, Ogawa T, Shimizu S, <i> et al.</i>: Epidermal growth factor receptor inhibitor AG1478 inhibits mucus hypersecretion in airway epithelium. <i>Am J Rhinol Allergy.</i> 2016; <b>30</b>(1): 1–6. <a target=xrefwindow id=d28924e3968 href="http://www.ncbi.nlm.nih.gov/pubmed/26867523">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3971 href="http://dx.doi.org/10.2500/ajra.2016.30.4263">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726147139">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d28924e3984 class=n-a></a>Burgel PR, Lazarus SC, Tam DC, <i> et al.</i>: Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. <i>J Immunol.</i> 2001; <b>167</b>(10): 5948–54. <a target=xrefwindow id=d28924e3995 href="http://www.ncbi.nlm.nih.gov/pubmed/11698473">PubMed Abstract </a> | <a target=xrefwindow id=d28924e3998 href="http://dx.doi.org/10.4049/jimmunol.167.10.5948">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d28924e4008 class=n-a></a>Kim S, Lewis C, Nadel JA: CCL20/CCR6 feedback exaggerates epidermal growth factor receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H292) cells. <i>J Immunol.</i> 2011; <b>186</b>(6): 3392–400. <a target=xrefwindow id=d28924e4016 href="http://www.ncbi.nlm.nih.gov/pubmed/21300824">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4019 href="http://dx.doi.org/10.4049/jimmunol.1003377">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d28924e4028 class=n-a></a>Le Cras TD, Acciani TH, Mushaben EM, <i> et al.</i>: Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2011; <b>300</b>(3): L414–21. <a target=xrefwindow id=d28924e4039 href="http://www.ncbi.nlm.nih.gov/pubmed/21224214">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4042 href="http://dx.doi.org/10.1152/ajplung.00346.2010">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4046 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3064289">Free Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d28924e4055 class=n-a></a>Bossé Y, Thompson C, Stankova J, <i> et al.</i>: Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. <i>Am J Respir Cell Mol Biol.</i> 2006; <b>34</b>(6): 746–53. <a target=xrefwindow id=d28924e4066 href="http://www.ncbi.nlm.nih.gov/pubmed/16439802">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4069 href="http://dx.doi.org/10.1165/rcmb.2005-0309OC">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d28924e4078 class=n-a></a>Berlin AA, Hogaboam CM, Lukacs NW: Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. <i>Lab Invest.</i> 2006; <b>86</b>(6): 557–65. <a target=xrefwindow id=d28924e4086 href="http://www.ncbi.nlm.nih.gov/pubmed/16607380">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4089 href="http://dx.doi.org/10.1038/labinvest.3700419">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d28924e4098 class=n-a></a>Yamamoto N, Takeshita K, Shichijo M, <i> et al.</i>: The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents. <i>J Pharmacol Exp Ther.</i> 2003; <b>306</b>(3): 1174–81. <a target=xrefwindow id=d28924e4109 href="http://www.ncbi.nlm.nih.gov/pubmed/12766258">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4112 href="http://dx.doi.org/10.1124/jpet.103.052316">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d28924e4121 class=n-a></a>Matsunaga Y, Inoue H, Fukuyama S, <i> et al.</i>: Effects of a Janus kinase inhibitor, pyridone 6, on airway responses in a murine model of asthma. <i>Biochem Biophys Res Commun.</i> 2011; <b>404</b>(1): 261–7. <a target=xrefwindow id=d28924e4132 href="http://www.ncbi.nlm.nih.gov/pubmed/21111712">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4135 href="http://dx.doi.org/10.1016/j.bbrc.2010.11.104">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d28924e4145 class=n-a></a>Leung SY, Niimi A, Noble A, <i> et al.</i>: Effect of transforming growth factor-beta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. <i>J Pharmacol Exp Ther.</i> 2006; <b>319</b>(2): 586–94. <a target=xrefwindow id=d28924e4156 href="http://www.ncbi.nlm.nih.gov/pubmed/16888081">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4159 href="http://dx.doi.org/10.1124/jpet.106.109314">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d28924e4168 class=n-a></a>Possa SS, Charafeddine HT, Righetti RF, <i> et al.</i>: Rho-kinase inhibition attenuates airway responsiveness, inflammation, matrix remodeling, and oxidative stress activation induced by chronic inflammation. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2012; <b>303</b>(11): L939–52. <a target=xrefwindow id=d28924e4179 href="http://www.ncbi.nlm.nih.gov/pubmed/23002076">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4182 href="http://dx.doi.org/10.1152/ajplung.00034.2012">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d28924e4191 class=n-a></a>Kumar RK, Herbert C, Thomas PS, <i> et al.</i>: Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. <i>J Pharmacol Exp Ther.</i> 2003; <b>307</b>(1): 349–55. <a target=xrefwindow id=d28924e4202 href="http://www.ncbi.nlm.nih.gov/pubmed/12954795">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4205 href="http://dx.doi.org/10.1124/jpet.103.053819">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d28924e4214 class=n-a></a>Billington CK, Joseph SK, Swan C, <i> et al.</i>: Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition. <i>Am J Physiol.</i> 1999; <b>276</b>(3 Pt 1): L412–9. <a target=xrefwindow id=d28924e4225 href="http://www.ncbi.nlm.nih.gov/pubmed/10070104">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4228 href="http://dx.doi.org/10.1152/ajplung.1999.276.3.L412">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d28924e4237 class=n-a></a>Buckley J, Birrell MA, Maher SA, <i> et al.</i>: EP<sub>4</sub> receptor as a new target for bronchodilator therapy. <i>Thorax.</i> 2011; <b>66</b>(12): 1029–35. <a target=xrefwindow id=d28924e4251 href="http://www.ncbi.nlm.nih.gov/pubmed/21606476">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4255 href="http://dx.doi.org/10.1136/thx.2010.158568">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4258 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3221321">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d28924e4267 class=n-a></a>Birrell MA, Maher SA, Dekkak B, <i> et al.</i>: Anti-inflammatory effects of PGE<sub>2</sub> in the lung: role of the EP<sub>4</sub> receptor subtype. <i>Thorax.</i> 2015; <b>70</b>(8): 740–7. <a target=xrefwindow id=d28924e4285 href="http://www.ncbi.nlm.nih.gov/pubmed/25939749">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4288 href="http://dx.doi.org/10.1136/thoraxjnl-2014-206592">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4291 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4516010">Free Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d28924e4301 class=n-a></a>Tilley SL, Hartney JM, Erikson CJ, <i> et al.</i>: Receptors and pathways mediating the effects of prostaglandin E<sub>2</sub> on airway tone. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2003; <b>284</b>(4): L599–606. <a target=xrefwindow id=d28924e4315 href="http://www.ncbi.nlm.nih.gov/pubmed/12618422">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4319 href="http://dx.doi.org/10.1152/ajplung.00324.2002">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1163731"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e4328 class=n-a></a>Shah AS, Ben-Shahar Y, Moninger TO, <i> et al.</i>: Motile cilia of human airway epithelia are chemosensory. <i>Science.</i> 2009; <b>325</b>(5944): 1131–4. <a target=xrefwindow id=d28924e4339 href="http://www.ncbi.nlm.nih.gov/pubmed/19628819">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4342 href="http://dx.doi.org/10.1126/science.1173869">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4346 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2894709">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1163731">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d28924e4359 class=n-a></a>Aravamudan B, Thompson MA, Pabelick CM, <i> et al.</i>: Mitochondria in lung diseases. <i>Expert Rev Respir Med.</i> 2013; <b>7</b>(6): 631–46. <a target=xrefwindow id=d28924e4370 href="http://www.ncbi.nlm.nih.gov/pubmed/23978003">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4373 href="http://dx.doi.org/10.1586/17476348.2013.834252">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4377 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3977638">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727442441"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e4386 class=n-a></a>Prakash YS, Pabelick CM, Sieck GC: Mitochondrial Dysfunction in Airway Disease. <i>Chest.</i> 2017; <b>152</b>(3): 618–26. <a target=xrefwindow id=d28924e4394 href="http://www.ncbi.nlm.nih.gov/pubmed/28336486">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4397 href="http://dx.doi.org/10.1016/j.chest.2017.03.020">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4400 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5812762">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727442441">F1000 Recommendation</a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d28924e4413 class=n-a></a>Lambrecht BN, Hammad H: The immunology of asthma. <i>Nat Immunol.</i> 2015; <b>16</b>(1): 45–56. <a target=xrefwindow id=d28924e4421 href="http://www.ncbi.nlm.nih.gov/pubmed/25521684">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4424 href="http://dx.doi.org/10.1038/ni.3049">Publisher Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d28924e4433 class=n-a></a>Nair P: Anti-interleukin-5 monoclonal antibody to treat severe eosinophilic asthma. <i>N Engl J Med.</i> 2014; <b>371</b>(13): 1249–51. <a target=xrefwindow id=d28924e4441 href="http://www.ncbi.nlm.nih.gov/pubmed/25197762">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4444 href="http://dx.doi.org/10.1056/NEJMe1408614">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726279242"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e4454 class=n-a></a>Russell R, Brightling C: Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma. <i>Expert Rev Respir Med.</i> 2016; <b>10</b>(6): 607–17. <a target=xrefwindow id=d28924e4462 href="http://www.ncbi.nlm.nih.gov/pubmed/27058452">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4465 href="http://dx.doi.org/10.1080/17476348.2016.1176532">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726279242">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727243798"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e4478 class=n-a></a>Russell R, Brightling CE: Anti-IL-5 for Severe Asthma: Aiming High to Achieve Success. <i>Chest.</i> 2016; <b>150</b>(4): 766–8. <a target=xrefwindow id=d28924e4486 href="http://www.ncbi.nlm.nih.gov/pubmed/27719806">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4489 href="http://dx.doi.org/10.1016/j.chest.2016.06.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727243798">F1000 Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d28924e4502 class=n-a></a>Cho JY: Recent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinic. <i>Korean J Intern Med.</i> 2011; <b>26</b>(4): 367–83. <a target=xrefwindow id=d28924e4510 href="http://www.ncbi.nlm.nih.gov/pubmed/22205837">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4513 href="http://dx.doi.org/10.3904/kjim.2011.26.4.367">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4516 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3245385">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d28924e4525 class=n-a></a>Gould HJ, Sutton BJ: IgE in allergy and asthma today. <i>Nat Rev Immunol.</i> 2008; <b>8</b>(3): 205–17. <a target=xrefwindow id=d28924e4533 href="http://www.ncbi.nlm.nih.gov/pubmed/18301424">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4536 href="http://dx.doi.org/10.1038/nri2273">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d28924e4545 class=n-a></a>Bousquet J, Chiron R, Humbert M: Biologics in asthma: difficulties and drawbacks. <i>Expert Opin Biol Ther.</i> 2008; <b>8</b>(12): 1921–8. <a target=xrefwindow id=d28924e4553 href="http://www.ncbi.nlm.nih.gov/pubmed/18990078">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4556 href="http://dx.doi.org/10.1517/14712590802496928">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d28924e4565 class=n-a></a>McCracken JL, Tripple JW, Calhoun WJ: Biologic therapy in the management of asthma. <i>Curr Opin Allergy Clin Immunol.</i> 2016; <b>16</b>(4): 375–82. <a target=xrefwindow id=d28924e4573 href="http://www.ncbi.nlm.nih.gov/pubmed/27362324">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4576 href="http://dx.doi.org/10.1097/ACI.0000000000000284">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4579 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5405559">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d28924e4589 class=n-a></a>Darveaux J, Busse WW: Biologics in asthma--the next step toward personalized treatment. <i>J Allergy Clin Immunol Pract.</i> 2015; <b>3</b>(2): 152–60; quiz 161. <a target=xrefwindow id=d28924e4597 href="http://www.ncbi.nlm.nih.gov/pubmed/25754716">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4600 href="http://dx.doi.org/10.1016/j.jaip.2014.09.014">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4603 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4774509">Free Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d28924e4612 class=n-a></a>Godar M, Blanchetot C, de Haard H, <i> et al.</i>: Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. <i>MAbs.</i> 2018; <b>10</b>(1): 34–45. <a target=xrefwindow id=d28924e4623 href="http://www.ncbi.nlm.nih.gov/pubmed/29035619">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4626 href="http://dx.doi.org/10.1080/19420862.2017.1392425">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5800381">Free Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d28924e4639 class=n-a></a>Wu P, Nielsen TE, Clausen MH: FDA-approved small-molecule kinase inhibitors. <i>Trends Pharmacol Sci.</i> 2015; <b>36</b>(7): 422–39. <a target=xrefwindow id=d28924e4647 href="http://www.ncbi.nlm.nih.gov/pubmed/25975227">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4650 href="http://dx.doi.org/10.1016/j.tips.2015.04.005">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726496289"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e4659 class=n-a></a>Barnes PJ: Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. <i>Pharmacol Rev.</i> 2016; <b>68</b>(3): 788–815. <a target=xrefwindow id=d28924e4667 href="http://www.ncbi.nlm.nih.gov/pubmed/27363440">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4670 href="http://dx.doi.org/10.1124/pr.116.012518">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726496289">F1000 Recommendation</a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727332024"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e4683 class=n-a></a>Khorasanizadeh M, Eskian M, Gelfand EW, <i> et al.</i>: Mitogen-activated protein kinases as therapeutic targets for asthma. <i>Pharmacol Ther.</i> 2017; <b>174</b>: 112–26. <a target=xrefwindow id=d28924e4694 href="http://www.ncbi.nlm.nih.gov/pubmed/28223227">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4697 href="http://dx.doi.org/10.1016/j.pharmthera.2017.02.024">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727332024">F1000 Recommendation</a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d28924e4710 class=n-a></a>Kim DH, Jung WS, Kim ME, <i> et al.</i>: Genistein inhibits pro-inflammatory cytokines in human mast cell activation through the inhibition of the ERK pathway. <i>Int J Mol Med.</i> 2014; <b>34</b>(6): 1669–74. <a target=xrefwindow id=d28924e4721 href="http://www.ncbi.nlm.nih.gov/pubmed/25319548">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4724 href="http://dx.doi.org/10.3892/ijmm.2014.1956">Publisher Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d28924e4734 class=n-a></a>Kono Y, Nishiuma T, Okada T, <i> et al.</i>: Sphingosine kinase 1 regulates mucin production via ERK phosphorylation. <i>Pulm Pharmacol Ther.</i> 2010; <b>23</b>(1): 36–42. <a target=xrefwindow id=d28924e4745 href="http://www.ncbi.nlm.nih.gov/pubmed/19835973">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4748 href="http://dx.doi.org/10.1016/j.pupt.2009.10.005">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d28924e4757 class=n-a></a>Guntur VP, Reinero CR: The potential use of tyrosine kinase inhibitors in severe asthma. <i>Curr Opin Allergy Clin Immunol.</i> 2012; <b>12</b>(1): 68–75. <a target=xrefwindow id=d28924e4765 href="http://www.ncbi.nlm.nih.gov/pubmed/22157153">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4768 href="http://dx.doi.org/10.1097/ACI.0b013e32834ecb4f">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d28924e4777 class=n-a></a>Amishima M, Munakata M, Nasuhara Y, <i> et al.</i>: Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. <i>Am J Respir Crit Care Med.</i> 1998; <b>157</b>(6 Pt 1): 1907–12. <a target=xrefwindow id=d28924e4788 href="http://www.ncbi.nlm.nih.gov/pubmed/9620926">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4791 href="http://dx.doi.org/10.1164/ajrccm.157.6.9609040">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d28924e4800 class=n-a></a>Polosa R, Puddicombe SM, Krishna MT, <i> et al.</i>: Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. <i>J Allergy Clin Immunol.</i> 2002; <b>109</b>(1): 75–81. <a target=xrefwindow id=d28924e4811 href="http://www.ncbi.nlm.nih.gov/pubmed/11799369">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4814 href="http://dx.doi.org/10.1067/mai.2002.120274">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d28924e4823 class=n-a></a>Takeyama K, Dabbagh K, Lee HM, <i> et al.</i>: Epidermal growth factor system regulates mucin production in airways. <i>Proc Natl Acad Sci U S A.</i> 1999; <b>96</b>(6): 3081–6. <a target=xrefwindow id=d28924e4834 href="http://www.ncbi.nlm.nih.gov/pubmed/10077640">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4837 href="http://dx.doi.org/10.1073/pnas.96.6.3081">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4841 href="http://www.ncbi.nlm.nih.gov/pmc/articles/15898">Free Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d28924e4850 class=n-a></a>Takeyama K, Fahy JV, Nadel JA: Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. <i>Am J Respir Crit Care Med.</i> 2001; <b>163</b>(2): 511–6. <a target=xrefwindow id=d28924e4858 href="http://www.ncbi.nlm.nih.gov/pubmed/11179132">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4861 href="http://dx.doi.org/10.1164/ajrccm.163.2.2001038">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d28924e4871 class=n-a></a>Wu LS, Tan C, Wang LM, <i> et al.</i>: Variant in promoter region of platelet-derived growth factor receptor-alpha (PDGFRalpha) gene is associated with the severity and allergic status of childhood asthma. <i>Int Arch Allergy Immunol.</i> 2006; <b>141</b>(1): 37–46. <a target=xrefwindow id=d28924e4882 href="http://www.ncbi.nlm.nih.gov/pubmed/16804324">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4885 href="http://dx.doi.org/10.1159/000094180">Publisher Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d28924e4894 class=n-a></a>Leung TF, Wong GW, Ko FW, <i> et al.</i>: Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. <i>Int Arch Allergy Immunol.</i> 2005; <b>137</b>(1): 66–72. <a target=xrefwindow id=d28924e4905 href="http://www.ncbi.nlm.nih.gov/pubmed/15832052">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4908 href="http://dx.doi.org/10.1159/000085106">Publisher Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1022230"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e4917 class=n-a></a>Lee CG, Link H, Baluk P, <i> et al.</i>: Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. <i>Nat Med.</i> 2004; <b>10</b>(10): 1095–103. <a target=xrefwindow id=d28924e4928 href="http://www.ncbi.nlm.nih.gov/pubmed/15378055">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4931 href="http://dx.doi.org/10.1038/nm1105">Publisher Full Text </a> | <a target=xrefwindow id=d28924e4935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3434232">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1022230">F1000 Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d28924e4948 class=n-a></a>Asai K, Kanazawa H, Kamoi H, <i> et al.</i>: Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. <i>Clin Exp Allergy.</i> 2003; <b>33</b>(5): 595–9. <a target=xrefwindow id=d28924e4959 href="http://www.ncbi.nlm.nih.gov/pubmed/12752587">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4962 href="http://dx.doi.org/10.1046/j.1365-2222.2003.01576.x">Publisher Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d28924e4971 class=n-a></a>Da Silva CA, Blay F, Israel-Biet D, <i> et al.</i>: Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi. <i>Clin Exp Allergy.</i> 2006; <b>36</b>(3): 317–24. <a target=xrefwindow id=d28924e4982 href="http://www.ncbi.nlm.nih.gov/pubmed/16499642">PubMed Abstract </a> | <a target=xrefwindow id=d28924e4985 href="http://dx.doi.org/10.1111/j.1365-2222.2006.02431.x">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a name=d28924e4994 class=n-a></a>Makowska JS, Cieslak M, Kowalski ML: Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity. <i>BMC Pulm Med.</i> 2009; <b>9</b>: 27. <a target=xrefwindow id=d28924e5002 href="http://www.ncbi.nlm.nih.gov/pubmed/19480722">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5005 href="http://dx.doi.org/10.1186/1471-2466-9-27">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5008 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2701918">Free Full Text </a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d28924e5018 class=n-a></a>Nadel JA, Burgel PR: The role of epidermal growth factor in mucus production. <i>Curr Opin Pharmacol.</i> 2001; <b>1</b>(3): 254–8. <a target=xrefwindow id=d28924e5026 href="http://www.ncbi.nlm.nih.gov/pubmed/11712748">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5029 href="http://dx.doi.org/10.1016/S1471-4892(01)00045-5">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d28924e5038 class=n-a></a>Hamilton LM, Torres-Lozano C, Puddicombe SM, <i> et al.</i>: The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. <i>Clin Exp Allergy.</i> 2003; <b>33</b>(2): 233–40. <a target=xrefwindow id=d28924e5049 href="http://www.ncbi.nlm.nih.gov/pubmed/12580917">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5052 href="http://dx.doi.org/10.1046/j.1365-2222.2003.01593.x">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d28924e5061 class=n-a></a>Takeyama K, Dabbagh K, Jeong Shim J, <i> et al.</i>: Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. <i>J Immunol.</i> 2000; <b>164</b>(3): 1546–52. <a target=xrefwindow id=d28924e5072 href="http://www.ncbi.nlm.nih.gov/pubmed/10640773">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5075 href="http://dx.doi.org/10.4049/jimmunol.164.3.1546">Publisher Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d28924e5084 class=n-a></a>Takeyama K, Jung B, Shim JJ, <i> et al.</i>: Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2001; <b>280</b>(1): L165–72. <a target=xrefwindow id=d28924e5095 href="http://www.ncbi.nlm.nih.gov/pubmed/11133506 ">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5098 href="http://dx.doi.org/10.1152/ajplung.2001.280.1.L165">Publisher Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d28924e5107 class=n-a></a>Shao MX, Nadel JA: Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-α-converting enzyme. <i>J Immunol.</i> 2005; <b>175</b>(6): 4009–16. <a target=xrefwindow id=d28924e5115 href="http://www.ncbi.nlm.nih.gov/pubmed/16148149">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5118 href="http://dx.doi.org/10.4049/jimmunol.175.6.4009">Publisher Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d28924e5127 class=n-a></a>Woodruff PG, Wolff M, Hohlfeld JM, <i> et al.</i>: Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2010; <b>181</b>(5): 438–45. <a target=xrefwindow id=d28924e5138 href="http://www.ncbi.nlm.nih.gov/pubmed/20007923">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5141 href="http://dx.doi.org/10.1164/rccm.200909-1415OC">Publisher Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d28924e5151 class=n-a></a>Hirst SJ, Barnes PJ, Twort CH: PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. <i>Am J Physiol.</i> 1996; <b>270</b>(3 Pt 1): L415–28. <a target=xrefwindow id=d28924e5159 href="http://www.ncbi.nlm.nih.gov/pubmed/8638734">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5162 href="http://dx.doi.org/10.1152/ajplung.1996.270.3.L415">Publisher Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722979375"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e5171 class=n-a></a>Hirota JA, Ask K, Farkas L, <i> et al.</i>: <i>In vivo</i> role of platelet-derived growth factor-BB in airway smooth muscle proliferation in mouse lung. <i>Am J Respir Cell Mol Biol.</i> 2011; <b>45</b>(3): 566–72. <a target=xrefwindow id=d28924e5185 href="http://www.ncbi.nlm.nih.gov/pubmed/21216974">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5189 href="http://dx.doi.org/10.1165/rcmb.2010-0277OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722979375">F1000 Recommendation</a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d28924e5202 class=n-a></a>Humbert M, de Blay F, Garcia G, <i> et al.</i>: Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics. <i>Allergy.</i> 2009; <b>64</b>(8): 1194–201. <a target=xrefwindow id=d28924e5213 href="http://www.ncbi.nlm.nih.gov/pubmed/19614621">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5216 href="http://dx.doi.org/10.1111/j.1398-9995.2009.02122.x">Publisher Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a name=d28924e5225 class=n-a></a>Chetta A, Zanini A, Foresi A, <i> et al.</i>: Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. <i>Clin Exp Allergy.</i> 2005; <b>35</b>(11): 1437–42. <a target=xrefwindow id=d28924e5236 href="http://www.ncbi.nlm.nih.gov/pubmed/16297139">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5239 href="http://dx.doi.org/10.1111/j.1365-2222.2005.02360.x">Publisher Full Text </a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d28924e5248 class=n-a></a>Zanini A, Chetta A, Saetta M, <i> et al.</i>: Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. <i>J Allergy Clin Immunol.</i> 2007; <b>120</b>(2): 329–33. <a target=xrefwindow id=d28924e5259 href="http://www.ncbi.nlm.nih.gov/pubmed/17559912">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5262 href="http://dx.doi.org/10.1016/j.jaci.2007.04.021">Publisher Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d28924e5271 class=n-a></a>Hoshino M, Nakamura Y, Hamid QA: Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. <i>J Allergy Clin Immunol.</i> 2001; <b>107</b>(6): 1034–8. <a target=xrefwindow id=d28924e5279 href="http://www.ncbi.nlm.nih.gov/pubmed/11398081">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5282 href="http://dx.doi.org/10.1067/mai.2001.115626">Publisher Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a name=d28924e5292 class=n-a></a>Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. <i>J Allergy Clin Immunol.</i> 2001; <b>107</b>(2): 295–301. <a target=xrefwindow id=d28924e5300 href="http://www.ncbi.nlm.nih.gov/pubmed/11174196">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5303 href="http://dx.doi.org/10.1067/mai.2001.111928">Publisher Full Text </a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a name=d28924e5312 class=n-a></a>Simcock DE, Kanabar V, Clarke GW, <i> et al.</i>: Induction of angiogenesis by airway smooth muscle from patients with asthma. <i>Am J Respir Crit Care Med.</i> 2008; <b>178</b>(5): 460–8. <a target=xrefwindow id=d28924e5323 href="http://www.ncbi.nlm.nih.gov/pubmed/18556625">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5326 href="http://dx.doi.org/10.1164/rccm.200707-1046OC">Publisher Full Text </a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a name=d28924e5335 class=n-a></a>Simcock DE, Kanabar V, Clarke GW, <i> et al.</i>: Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. <i>Am J Respir Crit Care Med.</i> 2007; <b>176</b>(2): 146–53. <a target=xrefwindow id=d28924e5346 href="http://www.ncbi.nlm.nih.gov/pubmed/17463417">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5349 href="http://dx.doi.org/10.1164/rccm.200701-042OC">Publisher Full Text </a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a name=d28924e5358 class=n-a></a>Keglowich L, Roth M, Philippova M, <i> et al.</i>: Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-chemokines (ENA-78, GRO-α, and IL-8). <i>PLoS One.</i> 2013; <b>8</b>(12): e81494. <a target=xrefwindow id=d28924e5369 href="http://www.ncbi.nlm.nih.gov/pubmed/24339939">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5372 href="http://dx.doi.org/10.1371/journal.pone.0081494">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5376 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3855263">Free Full Text </a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1138870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e5385 class=n-a></a>Barbato A, Turato G, Baraldo S, <i> et al.</i>: Epithelial damage and angiogenesis in the airways of children with asthma. <i>Am J Respir Crit Care Med.</i> 2006; <b>174</b>(9): 975–81. <a target=xrefwindow id=d28924e5396 href="http://www.ncbi.nlm.nih.gov/pubmed/16917118">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5399 href="http://dx.doi.org/10.1164/rccm.200602-189OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1138870">F1000 Recommendation</a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a name=d28924e5412 class=n-a></a>Vrugt B, Wilson S, Bron A, <i> et al.</i>: Bronchial angiogenesis in severe glucocorticoid-dependent asthma. <i>Eur Respir J.</i> 2000; <b>15</b>(6): 1014–21. <a target=xrefwindow id=d28924e5423 href="http://www.ncbi.nlm.nih.gov/pubmed/10885418">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5426 href="http://dx.doi.org/10.1034/j.1399-3003.2000.01507.x">Publisher Full Text </a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a name=d28924e5436 class=n-a></a>Tanaka H, Yamada G, Saikai T, <i> et al.</i>: Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. <i>Am J Respir Crit Care Med.</i> 2003; <b>168</b>(12): 1495–9. <a target=xrefwindow id=d28924e5447 href="http://www.ncbi.nlm.nih.gov/pubmed/14512267">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5450 href="http://dx.doi.org/10.1164/rccm.200306-727OC">Publisher Full Text </a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a name=d28924e5459 class=n-a></a>Nagy JA, Benjamin L, Zeng H, <i> et al.</i>: Vascular permeability, vascular hyperpermeability and angiogenesis. <i>Angiogenesis.</i> 2008; <b>11</b>(2): 109–19. <a target=xrefwindow id=d28924e5470 href="http://www.ncbi.nlm.nih.gov/pubmed/18293091">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5473 href="http://dx.doi.org/10.1007/s10456-008-9099-z">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5477 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2480489">Free Full Text </a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a name=d28924e5486 class=n-a></a>Li X, Wilson JW: Increased vascularity of the bronchial mucosa in mild asthma. <i>Am J Respir Crit Care Med.</i> 1997; <b>156</b>(1): 229–33. <a target=xrefwindow id=d28924e5494 href="http://www.ncbi.nlm.nih.gov/pubmed/9230753">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5497 href="http://dx.doi.org/10.1164/ajrccm.156.1.9607066">Publisher Full Text </a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a name=d28924e5506 class=n-a></a>Kim YS, Hong SW, Choi JP, <i> et al.</i>: Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. <i>J Immunol.</i> 2009; <b>183</b>(8): 5113–20. <a target=xrefwindow id=d28924e5517 href="http://www.ncbi.nlm.nih.gov/pubmed/19786548">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5520 href="http://dx.doi.org/10.4049/jimmunol.0901566">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5524 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3385973">Free Full Text </a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733275363"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e5533 class=n-a></a>Lee HY, Hur J, Kim IK, <i> et al.</i>: Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model. <i>Exp Lung Res.</i> 2017; <b>43</b>(4–5): 187–96. <a target=xrefwindow id=d28924e5544 href="http://www.ncbi.nlm.nih.gov/pubmed/28696800">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5547 href="http://dx.doi.org/10.1080/01902148.2017.1339141">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733275363">F1000 Recommendation</a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a name=d28924e5560 class=n-a></a>Berlin AA, Lukacs NW: Treatment of cockroach allergen asthma model with imatinib attenuates airway responses. <i>Am J Respir Crit Care Med.</i> 2005; <b>171</b>(1): 35–9. <a target=xrefwindow id=d28924e5568 href="http://www.ncbi.nlm.nih.gov/pubmed/15374841">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5571 href="http://dx.doi.org/10.1164/rccm.200403-385OC">Publisher Full Text </a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a name=d28924e5581 class=n-a></a>Seow CJ, Chue SC, Wong WS: Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways <i>in vitro</i>. <i>Eur J Pharmacol.</i> 2002; <b>443</b>(1–3): 189–96. <a target=xrefwindow id=d28924e5592 href="http://www.ncbi.nlm.nih.gov/pubmed/12044809">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5595 href="http://dx.doi.org/10.1016/S0014-2999(02)01534-0">Publisher Full Text </a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a name=d28924e5604 class=n-a></a>Sakai H, Nishimura A, Watanabe Y, <i> et al.</i>: Involvement of Src family kinase activation in angiotensin II-induced hyperresponsiveness of rat bronchial smooth muscle. <i>Peptides.</i> 2010; <b>31</b>(12): 2216–21. <a target=xrefwindow id=d28924e5615 href="http://www.ncbi.nlm.nih.gov/pubmed/20863867">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5618 href="http://dx.doi.org/10.1016/j.peptides.2010.09.012">Publisher Full Text </a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a name=d28924e5627 class=n-a></a>Kudlacz E, Conklyn M, Andresen C, <i> et al.</i>: The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. <i>Eur J Pharmacol.</i> 2008; <b>582</b>(1–3): 154–61. <a target=xrefwindow id=d28924e5638 href="http://www.ncbi.nlm.nih.gov/pubmed/18242596">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5641 href="http://dx.doi.org/10.1016/j.ejphar.2007.12.024">Publisher Full Text </a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a name=d28924e5650 class=n-a></a>Ghoreschi K, Jesson MI, Li X, <i> et al.</i>: Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). <i>J Immunol.</i> 2011; <b>186</b>(7): 4234–43. <a target=xrefwindow id=d28924e5661 href="http://www.ncbi.nlm.nih.gov/pubmed/21383241">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5664 href="http://dx.doi.org/10.4049/jimmunol.1003668">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5668 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3108067">Free Full Text </a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a name=d28924e5677 class=n-a></a>Catley MC, Sukkar MB, Chung KF, <i> et al.</i>: Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. <i>Mol Pharmacol.</i> 2006; <b>70</b>(2): 697–705. <a target=xrefwindow id=d28924e5688 href="http://www.ncbi.nlm.nih.gov/pubmed/16687566">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5691 href="http://dx.doi.org/10.1124/mol.106.023150">Publisher Full Text </a></span></li><li><a name=ref-173 class=n-a></a><span class=label>173. </span>&nbsp;<span class=citation><a name=d28924e5700 class=n-a></a>Newton R, Holden NS, Catley MC, <i> et al.</i>: Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors. <i>J Pharmacol Exp Ther.</i> 2007; <b>321</b>(2): 734–42. <a target=xrefwindow id=d28924e5711 href="http://www.ncbi.nlm.nih.gov/pubmed/17322026">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5714 href="http://dx.doi.org/10.1124/jpet.106.118125">Publisher Full Text </a></span></li><li><a name=ref-174 class=n-a></a><span class=label>174. </span>&nbsp;<span class=citation><a name=d28924e5724 class=n-a></a>Doukas J, Eide L, Stebbins K, <i> et al.</i>: Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease. <i>J Pharmacol Exp Ther.</i> 2009; <b>328</b>(3): 758–65. <a target=xrefwindow id=d28924e5735 href="http://www.ncbi.nlm.nih.gov/pubmed/19056934">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5738 href="http://dx.doi.org/10.1124/jpet.108.144311">Publisher Full Text </a></span></li><li><a name=ref-175 class=n-a></a><span class=label>175. </span>&nbsp;<span class=citation><a name=d28924e5747 class=n-a></a>Wilson R, Cahn A, Deans A, <i> et al.</i>: Safety, tolerability and pharmacokinetics (PK) of single and repeat nebulised doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy male subjects in a phase I study. <i>Eur Respir J.</i> 2013; <b>42</b>: 729. <a target=xrefwindow id=d28924e5758 href="http://erj.ersjournals.com/content/erj/42/Suppl_57/P729.full.pdf">Reference Source</a></span></li><li><a name=ref-176 class=n-a></a><span class=label>176. </span>&nbsp;<span class=citation><a name=d28924e5767 class=n-a></a>Massagué J: TGFβ signalling in context. <i>Nat Rev Mol Cell Biol.</i> 2012; <b>13</b>(10): 616–30. <a target=xrefwindow id=d28924e5775 href="http://www.ncbi.nlm.nih.gov/pubmed/22992590">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5778 href="http://dx.doi.org/10.1038/nrm3434">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5781 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4027049">Free Full Text </a></span></li><li><a name=ref-177 class=n-a></a><span class=label>177. </span>&nbsp;<span class=citation><a name=d28924e5790 class=n-a></a>Kokturk N, Tatlicioglu T, Memis L, <i> et al.</i>: Expression of transforming growth factor beta1 in bronchial biopsies in asthma and COPD. <i>J Asthma.</i> 2003; <b>40</b>(8): 887–93. <a target=xrefwindow id=d28924e5801 href="http://www.ncbi.nlm.nih.gov/pubmed/14736088">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5804 href="http://dx.doi.org/10.1081/JAS-120023580">Publisher Full Text </a></span></li><li><a name=ref-178 class=n-a></a><span class=label>178. </span>&nbsp;<span class=citation><a name=d28924e5813 class=n-a></a>Balzar S, Chu HW, Silkoff P, <i> et al.</i>: Increased TGF-beta2 in severe asthma with eosinophilia. <i>J Allergy Clin Immunol.</i> 2005; <b>115</b>(1): 110–7. <a target=xrefwindow id=d28924e5824 href="http://www.ncbi.nlm.nih.gov/pubmed/15637555">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5827 href="http://dx.doi.org/10.1016/j.jaci.2004.09.034">Publisher Full Text </a></span></li><li><a name=ref-179 class=n-a></a><span class=label>179. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726091409"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e5836 class=n-a></a>Aschner Y, Downey GP: Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease. <i>Am J Respir Cell Mol Biol.</i> 2016; <b>54</b>(5): 647–55. <a target=xrefwindow id=d28924e5844 href="http://www.ncbi.nlm.nih.gov/pubmed/26796672">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5847 href="http://dx.doi.org/10.1165/rcmb.2015-0391TR">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4942197">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726091409">F1000 Recommendation</a></span></li><li><a name=ref-180 class=n-a></a><span class=label>180. </span>&nbsp;<span class=citation><a name=d28924e5864 class=n-a></a>Goldsmith AM, Bentley JK, Zhou L, <i> et al.</i>: Transforming growth factor-beta induces airway smooth muscle hypertrophy. <i>Am J Respir Cell Mol Biol.</i> 2006; <b>34</b>(2): 247–54. <a target=xrefwindow id=d28924e5875 href="http://www.ncbi.nlm.nih.gov/pubmed/16239645">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5878 href="http://dx.doi.org/10.1165/rcmb.2005-0166OC">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5882 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2644185">Free Full Text </a></span></li><li><a name=ref-181 class=n-a></a><span class=label>181. </span>&nbsp;<span class=citation><a name=d28924e5891 class=n-a></a>Xie S, Sukkar MB, Issa R, <i> et al.</i>: Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2007; <b>293</b>(1): L245–53. <a target=xrefwindow id=d28924e5902 href="http://www.ncbi.nlm.nih.gov/pubmed/17468136">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5905 href="http://dx.doi.org/10.1152/ajplung.00068.2007">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5909 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1934553">Free Full Text </a></span></li><li><a name=ref-182 class=n-a></a><span class=label>182. </span>&nbsp;<span class=citation><a name=d28924e5918 class=n-a></a>Herbertz S, Sawyer JS, Stauber AJ, <i> et al.</i>: Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. <i>Drug Des Devel Ther.</i> 2015; <b>9</b>: 4479–99. <a target=xrefwindow id=d28924e5929 href="http://www.ncbi.nlm.nih.gov/pubmed/26309397">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5932 href="http://dx.doi.org/10.2147/DDDT.S86621">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5936 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4539082">Free Full Text </a></span></li><li><a name=ref-183 class=n-a></a><span class=label>183. </span>&nbsp;<span class=citation><a name=d28924e5945 class=n-a></a>Carlin S, Poronnik P, Cook DI, <i> et al.</i>: An antisense of protein kinase C-zeta inhibits proliferation of human airway smooth muscle cells. <i>Am J Respir Cell Mol Biol.</i> 2000; <b>23</b>(4): 555–9. <a target=xrefwindow id=d28924e5956 href="http://www.ncbi.nlm.nih.gov/pubmed/11017922">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5959 href="http://dx.doi.org/10.1165/ajrcmb.23.4.4197">Publisher Full Text </a></span></li><li><a name=ref-184 class=n-a></a><span class=label>184. </span>&nbsp;<span class=citation><a name=d28924e5968 class=n-a></a>Mochly-Rosen D, Das K, Grimes KV: Protein kinase C, an elusive therapeutic target? <i>Nat Rev Drug Discov.</i> 2012; <b>11</b>(12): 937–57. <a target=xrefwindow id=d28924e5976 href="http://www.ncbi.nlm.nih.gov/pubmed/23197040">PubMed Abstract </a> | <a target=xrefwindow id=d28924e5979 href="http://dx.doi.org/10.1038/nrd3871">Publisher Full Text </a> | <a target=xrefwindow id=d28924e5982 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3760692">Free Full Text </a></span></li><li><a name=ref-185 class=n-a></a><span class=label>185. </span>&nbsp;<span class=citation><a name=d28924e5991 class=n-a></a>Schaafsma D, Bos IS, Zuidhof AB, <i> et al.</i>: The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2008; <b>295</b>(1): L214–9. <a target=xrefwindow id=d28924e6002 href="http://www.ncbi.nlm.nih.gov/pubmed/18487358">PubMed Abstract </a> | <a target=xrefwindow id=d28924e6005 href="http://dx.doi.org/10.1152/ajplung.00498.2007">Publisher Full Text </a></span></li><li><a name=ref-186 class=n-a></a><span class=label>186. </span>&nbsp;<span class=citation><a name=d28924e6015 class=n-a></a>Lee KY, Ito K, Hayashi R, <i> et al.</i>: NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. <i>J Immunol.</i> 2006; <b>176</b>(1): 603–15. <a target=xrefwindow id=d28924e6026 href="http://www.ncbi.nlm.nih.gov/pubmed/16365456">PubMed Abstract </a> | <a target=xrefwindow id=d28924e6029 href="http://dx.doi.org/10.4049/jimmunol.176.1.603">Publisher Full Text </a></span></li><li><a name=ref-187 class=n-a></a><span class=label>187. </span>&nbsp;<span class=citation><a name=d28924e6038 class=n-a></a>Dienstmann R, Rodon J, Serra V, <i> et al.</i>: Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors. <i>Mol Cancer Ther.</i> 2014; <b>13</b>(15): 1021–31. <a target=xrefwindow id=d28924e6049 href="http://www.ncbi.nlm.nih.gov/pubmed/24748656">PubMed Abstract </a> | <a target=xrefwindow id=d28924e6052 href="http://dx.doi.org/10.1158/1535-7163.MCT-13-0639">Publisher Full Text </a></span></li><li><a name=ref-188 class=n-a></a><span class=label>188. </span>&nbsp;<span class=citation><a name=d28924e6061 class=n-a></a>Norman P: Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease. <i>Expert Opin Investig Drugs.</i> 2015; <b>24</b>(3): 383–92. <a target=xrefwindow id=d28924e6069 href="http://www.ncbi.nlm.nih.gov/pubmed/25599809">PubMed Abstract </a> | <a target=xrefwindow id=d28924e6072 href="http://dx.doi.org/10.1517/13543784.2015.1006358">Publisher Full Text </a></span></li><li><a name=ref-189 class=n-a></a><span class=label>189. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732331733"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28924e6081 class=n-a></a>Johnstone TB, Smith KH, Koziol-White CJ, <i> et al.</i>: PDE8 Is Expressed in Human Airway Smooth Muscle and Selectively Regulates cAMP Signaling by β<sub>2</sub>-Adrenergic Receptors and Adenylyl Cyclase 6. <i>Am J Respir Cell Mol Biol.</i> 2018; <b>58</b>(4): 530–41. <a target=xrefwindow id=d28924e6095 href="http://www.ncbi.nlm.nih.gov/pubmed/29262264">PubMed Abstract </a> | <a target=xrefwindow id=d28924e6099 href="http://dx.doi.org/10.1165/rcmb.2017-0294OC">Publisher Full Text </a> | <a target=xrefwindow id=d28924e6102 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5894499">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732331733">F1000 Recommendation</a></span></li><li><a name=ref-190 class=n-a></a><span class=label>190. </span>&nbsp;<span class=citation><a name=d28924e6115 class=n-a></a>Fujitani Y, Trifilieff A: <i>In vivo</i> and <i>in vitro</i> effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. <i>Am J Respir Crit Care Med.</i> 2003; <b>167</b>(2): 193–8. <a target=xrefwindow id=d28924e6129 href="http://www.ncbi.nlm.nih.gov/pubmed/12406821">PubMed Abstract </a> | <a target=xrefwindow id=d28924e6133 href="http://dx.doi.org/10.1164/rccm.200205-455OC">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 May 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-680&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-680&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, USA<br/> <p> <div class=margin-bottom> Ajay P. Nayak <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Deepak A. Deshpande <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> <div class=margin-bottom> Raymond B. Penn <br/> <span>Roles: </span> Conceptualization, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-680/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 30 May 2018, 7:680 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14581.1">https://doi.org/10.12688/f1000research.14581.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Nayak AP <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15868 data-id=14581 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14581.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-680/v1/pdf?article_uuid=3c767673-f55b-4a88-8419-b0a93f127a51" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14581.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Nayak AP, Deshpande DA and Penn RB. New targets for resolution of airway remodeling in obstructive lung diseases [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):680 (<a href="https://doi.org/10.12688/f1000research.14581.1" target=_blank>https://doi.org/10.12688/f1000research.14581.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14581 id=mobile-track-article-signin-14581 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14581?target=/articles/7-680"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15868 /> <input name=articleId type=hidden value=14581 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Rennolds Ostrom</strong>, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Omar Tliba</strong>, Rutgers Institute for Translational Medicine and Science, Child Health Institute of New Jersey, The State University of New Jersey, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 May 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-680&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-680&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=34739-34308></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=34738-34309></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-680/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>30 May 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Rennolds Ostrom</strong>, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Omar Tliba</strong>, Rutgers Institute for Translational Medicine and Science, Child Health Institute of New Jersey, The State University of New Jersey, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-680&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-680/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "New targets for resolution of airway remodeling...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-680/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-680/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-680/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Nayak AP et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-680/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-680",
            templates : {
                twitter : "New targets for resolution of airway remodeling in obstructive.... Nayak AP et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-680/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: New targets for resolution of airway remodeling in obstructive lung diseases", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: New targets for resolution of airway remodeling in obstructive lung diseases", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14581/15868")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15868");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "34308": 0,
                           "34309": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "9e0906bf-7310-4f1f-a3e1-554b9ca41787";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-680.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-680.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-680.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-680.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-680.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>